慶應義塾大学医学部 血液内科

Division of Hematology Department of Medicine Keio University School of Medicine

血液内科トップ研究 > 業績集

研究 業績集

2021年

論文

  1. Kubota Y, Seki M, Kawai T, Isobe T, Yoshida M, Sekiguchi M, Kimura S, Watanabe K, Sato-Otsubo A, Yoshida K, Suzuki H, Kataoka K, Fujii Y, Shiraishi Y, Chiba K, Tanaka H, Hiwatari M, Oka A, Hayashi Y, Miyano S, Ogawa S, Hata K, Tanaka Y, Takita J. Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets. Commun Biol. 2021;3(1):544
  2. Nakayama H, Yamazaki R, Kato J, Koda Y, Sakurai M, Mori T. Impact of Specific Antibody Level on Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation. Transplant Cell Ther. 2021;27(2):174.e1-174.e5
  3. Hirai I, Funakoshi T, Kamijuku H, Fukuda K, Mori M, Sakurai M, Koda Y, Kato J, Mori T, Watanabe N, Noji S, Yaguchi T, Iwata T, Ohta S, Fujita T, Tanosaki R, Handa M, Okamoto S, Amagai M, Kawakami Y. Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors. Cancer Sci. 2021;112(8):3163-3172
  4. Yamazaki R, Koda Y, Abe R, Sakurai M, Kikuchi T, Kato J, Ouchi T, Mikami S, Mori T. [Spontaneous remission of relapsed skin lesions of ALK-positive anaplastic large cell lymphoma after autologous stem cell transplantation]. Rinsho Ketsueki. 2021;62(1):25-29
  5. Mori T, Koda Y, Kato J, Sakurai M, Uwamino Y, Hasegawa N. Usefulness of the FilmArray Meningitis/Encephalitis Panel in diagnosis of central nervous system infection after allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2021. in press
  6. Mori T, Kikuchi T, Yamazaki R, Koda Y, Saburi M, Sakurai M, Shigematsu N, Okamoto S, Kato J. Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2021;113(6):877-883
  7. Kikuchi T, Mizuno K, Mori T. [Early recurrence of pneumocystis pneumonia post trimethoprim-sulfamethoxazole therapy that developed after chemotherapy for follicular lymphoma]. Rinsho Ketsueki. 2021;62(1):42-46
  8. Tanigawa T, Sakurai M, Kato J, Mizuno K, Fujita S, Koda Y, Kikuchi T, Shimizu T, Okamoto S, Kataoka K. Successful ibrutinib treatment for central nervous system relapse of chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2021. in press
  9. Sakurai M, Mori T, Kato K, Kanaya M, Mizuno S, Shiratori S, Wakayama T, Uchida N, Kobayashi H, Kubo K, Amano I, Ohta T, Miyazaki Y, Kanda J, Fukuda T, Atsuta Y, Kondo E; Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant. 2021;56(6):1462-1466
  10. Sakurai M, Nannya Y, Yamazaki R, Yamaguchi K, Koda Y, Abe R, Yokoyama K, Ogawa S, Mori T. Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies. Ann Hematol. 2021. in press
  11. Kikuchi T, Mori T, Ohwada C, Onoda M, Shimizu H, Yokoyama H, Onizuka M, Koda Y, Kato J, Takeda Y, Hino Y, Mishina T, Sakaida E, Shono K, Nagao Y, Yokota A, Matsumoto K, Morita K, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine. Int J Hematol. 2021;113(1):128-133
  12. Karigane D, Kasahara H, Shiroshita K, Fujita S, Kobayashi H, Tamaki S, Yamazaki R, Yahagi K, Yatabe Y, Kondoh N, Arai T, Katagiri H, Shimizu N, Sakurai M, Kikuchi T, Kato J, Shimizu T, Hayakawa T, Yaguchi T, Matsushita M, Nakajima H, Kawakami Y, Murata M, Mori T, Sasaki T, Okamoto S, Takubo K. Detection of residual disease in chronic myeloid leukemia utilizing genomic next generation sequencing reveals persistence of differentiated Ph(+) B cells but not bone marrow stem/progenitors. Leuk Lymphoma. 2021;62(3):679-687
  13. Amikura T, Kikuchi T, Kato J, Koda Y, Sakurai M, Yamazaki R, Mikita K, Saburi M, Nakazato T, Mori T. Toxoplasmosis after allogeneic hematopoietic stem cell transplantation: Impact of serostatus-based management. Transpl Infect Dis. 2021;23(3):13506
  14. Mori T, Kikuchi T, Koh M, Koda Y, Yamazaki R, Sakurai M, Tomita Y, Ozawa Y, Kohashi S, Abe R, Saburi M, Kato J. Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening. Bone Marrow Transplant. 2021;56(6):1266-1271
  15. Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Miyazaki T, Aotsuka N, Gotoh M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter Analysis. Transplant Cell Ther. 2021;27(1):70.e1-70.e8
  16. Nakasone H, Kako S, Mori T, Takahashi S, Onizuka M, Fujiwara SI, Sakura T, Sakaida E, Yokota A, Aotsuka N, Hagihara M, Tsukada N, Hatta Y, Usuki K, Watanabe R, Gotoh M, Fujisawa S, Yano S, Kanamori H, Okamoto S, Kanda Y. Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia. Bone Marrow Transplant. 2021;56(6):1402-1412
  17. Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Miyazaki T, Aotsuka N, Gotoh M, Watanabe R, Shono K, Kanamori H, Kanda Y, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis. Ann Hematol. 2021. in press
  18. Saito Y, Koya J, Kataoka K (corresponding). Multiple mutations within individual oncogenes. Cancer Sci. 2021;112(2):483-489
  19. Shimada K, Yoshida K, Suzuki Y, Iriyama C, Inoue Y, Sanada M, Kataoka K, Yuge M, Takagi Y, Kusumoto S, Masaki Y, Ito T, Inagaki Y, Okamoto A, Kuwatsuka Y, Nakatochi M, Shimada S, Miyoshi H, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Shiozawa Y, Nannya Y, Okabe A, Kohno K, Atsuta Y, Ohshima K, Nakamura S, Ogawa S, Tomita A, Kiyoi H. Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma. Blood. 2021;137(11):1491-1502
  20. Boons E, Nogueira TC, Dierckx T, Menezes SM, Jacquemyn M, Tamir S, Landesman Y, Farré L, Bittencourt A, Kataoka K, Ogawa S, Snoeck R, Andrei G, Van Weyenbergh J, Daelemans D. XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis. Blood Cancer J. 2021;11(2):27
  21. Okabe M, Morishita T, Yasuda T, Sakaguchi H, Sanada M, Kataoka K, Ogawa S, Shiraishi Y, Ichiki T, Kawaguchi Y, Ohbiki M, Matsumoto R, Osaki M, Goto T, Ozawa Y, Miyamura K. Targeted deep next generation sequencing identifies potential somatic and germline variants for predisposition to familial Burkitt lymphoma. Eur J Haematol. 2021;107(1):166-169
  22. Murata M, Terakura S, Wake A, Miyao K, Ikegame K, Uchida N, Kataoka K, Miyamoto T, Onizuka M, Eto T, Doki N, Ota S, Sato M, Hashii Y, Ichinohe T, Fukuda T, Atsuta Y, Okamoto S, Teshima T. Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence. Bone Marrow Transplant. 2021. in press
  23. Fujii Y, Sato Y, Suzuki H, Kakiuchi N, Yoshizato T, Lenis AT, Maekawa S, Yokoyama A, Takeuchi Y, Inoue Y, Ochi Y, Shiozawa Y, Aoki K, Yoshida K, Kataoka K, Nakagawa MM, Nannya Y, Makishima H, Miyakawa J, Kawai T, Morikawa T, Shiraishi Y, Chiba K, Tanaka H, Nagae G, Sanada M, Sugihara E, Sato TA, Nakagawa T, Fukayama M, Ushiku T, Aburatani H, Miyano S, Coleman JA, Homma Y, Solit DB, Kume H, Ogawa S. Molecular classification and diagnostics of upper urinary tract urothelial carcinoma. Cancer Cell. 2021;39(6):793-809
  24. Honda A, Koya J, Yoshimi A, Miyauchi M, Taoka K, Kataoka K, Arai S, Kurokawa M. Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemia. Exp Hematol. 2021. in press
  25. Murakami K, Kurotaki D, Kawase W, Soma S, Fukuchi Y, Kunimoto H, Yoshimi R, Koide S, Oshima M, Hishiki T, Hayakawa N, Matsuura T, Oda M, Yanagisawa K, Kobayashi H, Haraguchi M, Atobe Y, Funakoshi K, Iwama A, Takubo K, Okamoto S, Tamura T, Nakajima H. OGT Regulates Hematopoietic Stem Cell Maintenance via PINK1-Dependent Mitophagy. Cell Rep. 2021;34(1):108579
  26. Murakami K, Sasaki H, Nishiyama A, Kurotaki D, Kawase W, Ban T, Nakabayashi J, Kanzaki S, Sekita Y, Nakajima H, Ozato K, Kimura T, Tamura T. A RUNX-CBFβ-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes. Nat Immunol. 2021;22(3):301

学会発表

  1. 諫田 淳也、林 裕美、Ruggeri Annalisa、木村 文彦、Volt Fernanda、高橋 聡、賀古 真一、Tozatto-Maio Karina、柳田 正光、Sanz Guillermo、内田 直之、Angelucci Emanuele、加藤せい子、Mohty Mohamad、Forcade Edouard、田中 正嗣、Sierra Jorge、太田 貴徳、Saccardi Riccardo、福田 隆浩、一戸 辰夫、木村 貴文、Rocha Vanderson、岡本真一郎、Nagler Arnon、熱田 由子、Gluckman Eliane. 欧州および日本における GVHD が成人単一臍帯血移植成績に及ぼす影響の比較. 第43回日本造血・免疫細胞療法学会(特別演題、2021年3月6日、東京)
  2. 政氏 伸夫、福田 隆浩、保仙 直毅、高折 晃史、衛藤 徹也、黒川 峰夫、赤司 浩一、大橋 一輝、田中 正嗣、宮村 耕一、前田 嘉信、石黒 卓朗、日野 雅之、小川 佳宏、内山 人二、岩﨑 浩己、甲田 祐也、久保 恒明、安藤 潔、益崎 裕章、奥村 廣和、中尾 眞二、末廣 陽子、宇都宮 與、堺田惠美子、豊嶋 崇徳、烏野 隆博、塚田 信弘、矢部 普正、小寺 良尚.同種末梢血ドナー調査 2020 の day 30 report data を用いた Poor mobilizer の解析. 第43回日本造血・免疫細胞療法学会(一般口演、2021年3月6日、東京)
  3. 上田 格弘、小沼 貴晶、青木 淳、高橋 聡、小澤 幸泰、森 毅彦、太田 秀一、衛藤 徹也、高田 覚、吉岡 聡、白鳥 聡一、賀古 真一、福田 隆浩、鬼塚 真仁、神田 善伸、熱田 由子、柳田 正光. AML 患者への骨髄破壊的同種造血幹細胞移植における TBI 分割回数の予後への影響. 第43回日本造血・免疫細胞療法学会(一般口演、2021年3月6日、東京)
  4. 賀古 真一、木村 俊一、和田 英則、小宮 佑介、仲宗根秀樹、櫻井 政寿、加藤 淳、田中 正嗣、藤井恵理子、立花 崇孝、山本 渉、萩原 真紀、渡部 玲子、横田 朗、中野 裕史、森 毅彦、中世古知昭、金森 平和、岡本真一郎、神田 善伸. アザシチジン時代における骨髄異形成症候群患者に対する移植決断時の治療戦略:KSGCT による前方視的検討. 第43回日本造血・免疫細胞療法学会(一般口演、2021年3月6日、東京)
  5. 篠原 明仁、進藤 理穂、池亀 和博、内田 直之、池田 宇次、森 毅彦、小林 光、芦田 隆司、宮本 敏浩、高山 信之、中澤 英之、神田 善伸、福田 隆浩、熱田 由子、近藤 英生. 悪性リンパ腫に対する同種造血幹細胞移植における前処置 FluBu4 と FluMel140 の比較. 第43回日本造血・免疫細胞療法学会(一般口演、2021年3月6日、東京)
  6. 竹中 克斗、大西 康、森 毅彦、平川 経晃、多田 雄真、内田 直之、小林 武、神田 善伸、小澤 幸泰、太田 秀一、飯田 浩充、福島健太郎、木村 貴文、福田 隆浩、熱田 由子、松尾恵太郎、山崎 宏人1、仲宗根秀樹. 再生不良性貧血に対する同種造血幹細胞移植後サイトメガロウイルス再活性化の移植後予後に及ぼす影響. 第43回日本造血・免疫細胞療法学会(一般口演、2021年3月6日、東京)
  7. 松浦 朋子、黒澤 彩子、山口 拓洋、森 文子、森 毅彦、田中 正嗣、近藤 忠一、坂本 周子、藤井 伸治、一戸 辰夫、奈良 美保、前田 智也、藤澤 信、名和由一郎、中邑 幸伸、南口 仁志、大西 康、高野久仁子、高橋 都、福田 隆浩. 同種移植後患者の就労に関する実態調査-慢性 GVHD 等の自覚症状による仕事・生活への影響度に関する検討-. 第43回日本造血・免疫細胞療法学会(看護一般口演、2021年3月6日、東京)
  8. 片岡圭亮. 造血器腫瘍における免疫回避に寄与する遺伝子異常. 第43回日本造血・免疫細胞療法学会(特別演題、2021年3月7日、東京)
  9. 山﨑 理絵. 末梢血幹細胞採取とPlerixafor. 第69回日本輸血・細胞治療学会学術総会(教育講演、2021年6月4日、東京)
  10. 山﨑 理絵. 幹細胞採取での工夫や取り組み「当院における末梢血幹細胞採取」. 第69回日本輸血・細胞治療学会学術総会(指定教育セミナー、2021年6月4日、東京)
  11. 山﨑 理絵、他. CAR-T療法のためのリンパ球採取:採取CD3リンパ球数の予測法の検討.第69回日本輸血・細胞治療学会学術総会(一般口演、2021年6月4日、東京)
  12. 古屋 淳史、斎藤 優樹、下田 和哉、片岡 圭亮. 悪性リンパ腫のシングルセル解析による病態解明. 第61回日本リンパ網内系学会総会(シンポジウム、2021年6月26日、岡山)
  13. 片岡圭亮. 悪性リンパ腫における遺伝子解析研究. 第83回日本血液学会学術集会(教育講演、2021年9月23日、Online)
  14. 金夏倫. Castleman 病に類似した症状を呈したアトピー性皮膚炎による皮膚病性リンパ節症の一例. 第83回日本血液学会学術集会(ポスター、2021年9月23日、Online)
  15. 谷川智彦. 成人同種造血幹細胞移植患者における expanded HCT-CI の有用性. 第83回日本血液学会学術集会(ポスター、2021年9月23日、Online)
  16. Kosuke Takano ,Suguru Fukuhara ,Toshikatsu Horiuchi ,Toshikuni Kawamura ,Noriaki Tachi ,Takuya Izumi ,Koji Izutsu ,Keisuke Kataoka ,Shinichi Kobayashi ,Fumihiko Kimura . Myeloid/lymphoid neoplasm with ETV6-LYN fusion gene transformed to acute leukemia with monosomy 7. 第83回日本血液学会学術集会(ポスター、2021年9月23日、Online)
  17. Kohei Shiroshita, Hiroshi Kobayashi, Keisuke Kataoka, Keiyo Takubo. 5 Novel genome editing system optimized to preserve the hematopoietic stem cell function and phenotype. 第83回日本血液学会学術集会(一般口演、2021年9月23日、Online)
  18. Shohei Mizuno, Akiyoshi Takami, Ichiro Hanamura, Koji Kawamura, Yutaka Shimazu, Akira Hangaishi, Nobuhiro Tsukada, Shinichi Kako, Taku Kikuchi, Shuichi Ota, Noriko Doki, Shinsuke Iida, Satoshi Yoshioka, Masashi Sawa, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Hiroyuki Takamatsu. Autologous hematopoietic cell transplantation in multiple myeloma patients infected with HBV or HCV. 第83回日本血液学会学術集会(一般口演、2021年9月23日、Online)
  19. 片岡圭亮. 造血器腫瘍臨床におけるパネル検査の活用:診断・予後予測. 第83回日本血液学会学術集会(シンポジウム、2021年9月24日、Online)
  20. Junji Koya, Yuki Saito, Takuro Kameda, Mitsuhiro Yuasa, Yasunori Kogure, Marni Mcclure, Sumito Shingaki, Mariko Tabata, Yuki Tahira, Keiichi Akizuki, Ayako Kamiunten, Masaaki Sekine, Kotaro Shide, Yoko Kubuki, Tomonori Hidaka, Akira Kitanaka, Nobuaki Nakano, Atae Utsunomiya, Seishi Ogawa, Kazuya Shimoda, Keisuke Kataoka. Intercellular communication of PD-L1 proteins revealed by multi-modal single-cell analysis in ATL. 第83回日本血液学会学術集会(一般口演、2021年9月24日、Online)
  21. Mitsuhiro Yuasa ,Junji Koya ,Yuki Saito ,Takuro Kameda ,Yasunori Kogure ,Mcclure Marni ,Sumito Shingaki ,Mariko Tabata ,Ayako Kamiunten,Kotaro Shide ,Seishi Ogawa ,Kazuya Shimoda ,Keisuke Kataoka. Different post-transcriptional regulation of surface markers across cell types revealed by CITE-seq. 第83回日本血液学会学術集会(一般口演、2021年9月24日、Online)
  22. Shinya Fujita, Takayuki Morikawa, Yuki Sugiura, Takako Hishiki, Maiko Sezaki, Hitoshi Takizawa, Keisuke Kataoka, Makoto Suematsu, Keiyo Takubo. Non-neuronal acetylcholine derived from hematopoietic cells in bone marrow regulates B cell dynamics. 第83回日本血液学会学術集会(一般口演、2021年9月24日、Online)
  23. Takuro Kameda, Yasunori Kogure, Takako Yokomizo, Ayako Kamiunten, Junji Koya, Kotaro Shide, Sho Kubota, Yuki Tahira, Keiichi Akizuki, Masaaki Sekine, Tomonori Hidaka, Yoko Kubuki, Daisuke Morishita, Akira Kitanaka, Goro Sashida, Keisuke Kataoka, Seishi Ogawa, Kazuya Shimoda. CARD11E626K and HBZ form ATL-like gene expression profile and accelerate T-cell proliferation. 第83回日本血液学会学術集会(一般口演、2021年9月24日、Online)
  24. Sumito Shingaki ,Junji Koya ,Yuki Saito ,Mariko Tabata ,Marni B. McClure ,Kentaro Yamaguchi ,Mitsuhiro Yuasa ,Yuta Ito 1,Yasunori Kogure ,Keisuke Kataoka . Elucidation of the regulatory landscape of PD-L2 expression in B-cell lymphoma. 第83回日本血液学会学術集会(一般口演、2021年9月24日、Online)
  25. Kentaro Yamaguchi, Junji Koya, Kota Yoshifuji, Yuta Ito, Mitsuhiro Yuasa, Yuki Saito, Mariko Tabata, Sumito Shingaki, Yasuhiro Kogure, Kazutaka Nakashima, Koichi Oshima, Keisuke Kataoka. High-throughput screening to elucidate in vivo oncogenicity of lymphoma-related genetic alterations. 第83回日本血液学会学術集会(一般口演、2021年9月24日、Online)
  26. 久保田悠介. GATA1 変異を持つドナー由来臍帯血クローンから進展した移植後一過性骨髄増殖症. 第83回日本血液学会学術集会(一般口演、2021年9月25日、Online)
  27. 櫻井政寿. 初発 PTCL-NOS 症例に対する治療選択. 第83回日本血液学会学術集会(Clinical Debate、2021年9月25日、Online)
  28. Ayumi Fujimoto, Tatsuhiko Anzai ,Takahiro Fukuda ,Naoyuki Uchida ,Takanori Ohta ,Takehiko Mori ,Masashi Sawa ,Satoshi Yoshioka ,Toshihiro Miyamoto ,Hitoji Uchiyama ,Yuta Katayama Kenichi Matsuoka ,Souichi Shiratori ,Hideyuki Nakazawa ,Junya Kanda ,Tatsuo Ichinohe ,Yoshiko Atsuta ,Naoto Fujita ,Eisei Kondo ,Ritsuro Suzuki . Impact of event-free survival status after HSCT on subsequent survival in lymphoma patients. 第83回日本血液学会学術集会(一般口演、2021年9月25日、Online)
  29. Yusuke Kubota ,Masatoshi Sakurai ,Yasuhito Nannya ,Yasuhiro Kogure ,Kohei Shiroshita ,Kentaro Yamaguchi ,Shinya Fujita ,Yuya Koda ,Taku Kikuchi ,Takayuki Shimizu ,Jun Kato ,Seishi Ogawa,Keisuke Kataoka . Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in cord blood. 第83回日本血液学会学術集会(一般口演、2021年9月25日、Online)
  30. Yoko Edahiro ,Yoshinori Hashimoto ,Tomoki Ito ,Akihiko Gotoh ,Mika Nakamae ,Fumihiko Kimura ,Michiaki Koike ,Keita Kirito ,Hideho Wada ,Kensuke Usuki ,Takayuki Tanaka ,Takehiko Mori ,Satoshi Wakita ,Toshiki Saito ,Akiko Kada ,Akiko Saito ,Kazuya Shimoda ,Yuka Sugimoto ,Toshiro Kurokawa ,Akihiro Tomita ,Koichi Akashi ,Itaru Matsumura ,Katsuto Takenaka ,Norio Komatsu. Clinical characteristics of Japanese patients with polycythemia vera: JSH MPN-R18 study results. 第83回日本血液学会学術集会(一般口演、2021年9月25日、Online)
  31. Yoshinori Hashimoto ,Yoko Edahiro ,Tomoki Ito ,Akihiko Gotoh ,Mika Nakamae ,Fumihiko Kimura ,Michiaki Koike ,Keita Kirito ,Hideho Wada ,Kensuke Usuki ,Takayuki Tanaka ,Takehiko Mori ,Satoshi Wakita ,Toshiki Saito ,Akiko Kada ,Akiko Saito ,Kazuya Shimoda ,Yuka Sugimoto,Toshiro Kurokawa ,Akihiro Tomita ,Koichi Akashi ,Itaru Matsumura ,Katsuto Takenaka ,Norio Komatsu. A nationwide survey on Japanese patients with essential thrombocythemia: JSH-MPN-R18 study. 第83回日本血液学会学術集会(一般口演、2021年9月25日、Online)
  32. Tomonori Ochiai ,Yoshinori Hashimoto ,Yoko Edahiro ,Tomoki Ito ,Akihiko Gotoh ,Mika Nakamae ,Fumihiko Kimura ,Michiaki Koike ,Keita Kirito ,Hideho Wada ,Kensuke Usuki ,Takayuki Tanaka Takehiko Mori ,Satoshi Wakita ,Toshiki Saito ,Akiko Kada ,Akiko Saito ,Kazuya Shimoda,Yuka Sugimoto ,Toshiro Kurokawa,Akihiro Tomita,Koichi Akashi,Itaru Matsumura,Katsuto Takenaka,Norio Komatsu. Secondary malignancies in Japanese patients with myeloproliferative neoplasms: JSH-MPN-R18 study. 第83回日本血液学会学術集会(一般口演、2021年9月25日、Online)
  33. Kaito Harada ,Makoto Onizuka ,Takehiko Mori ,Hiroaki Shimizu ,Sachiko Seo ,Nobuyuki Aotsuka ,Yusuke Takeda ,Noritaka Sekiya ,Machiko Kusuda ,Shinichiro Fujiwara ,Sawako Shiraiwa ,Katsuhiro Shono ,Naoki Shingai ,Heiwa Kanamori ,Mamiko Momoki ,Satoru Takada ,Junichi Mukae ,Shinichi Masuda ,Kinuko Mitani ,Emiko Sakaida ,Tatsuki Tomikawa ,Satoshi Takahashi ,Kensuke Usuki ,Yoshinobu Kanda. Influenza virus infection after hematopoietic stem cell transplantation: a KSGCT multicenter survey. 第83回日本血液学会学術集会(一般口演、2021年9月25日、Online)
  34. 山口 健太郎、古屋 淳史、吉藤 康太、伊藤 勇太、湯淺 光博、斎藤 優樹、田畑 真梨子、新垣 清登、木暮 泰寛、大島 孝一、片岡 圭亮. 高効率スクリーニングによるリンパ腫関連遺伝子異常の生体内における造腫瘍能の網羅的解明. 第80回日本癌学会学術総会(一般口演、2021年9月30日、神奈川)
  35. 加藤淳. CAR-T 細胞治療における臨床運用の実際. 第80回日本癌学会学術総会(セミナー、2021年9月30日、神奈川)
  36. 竹田 淳恵、吉田 健一、依田 成玄、南谷 泰仁、越智 陽太郎、中川 正宏、佐伯 龍之介、白石 友一、永田 安伸、高折 晃史、千葉 滋、片岡 圭亮. 赤白血病におけるゲノム解析と治療標的の検討. 第80回日本癌学会学術総会(一般口演、2021年9月30日、神奈川)
  37. 白石 友一、新井 康仁、飯田 直子、千葉 健一、片岡 圭亮、柴田 龍弘. ロングリードを利用した後天的片側切断点の検出によるがんゲノムにおける複雑な構造異常の検出. 第80回日本癌学会学術総会(一般口演、2021年9月30日、神奈川)
  38. 片岡圭亮. 先端ゲノム技術を用いたATLの病態解析. 第7回日本HTLV-1学会学術集会(シンポジウム、2021年11月5日、熊本)

2020年

論文

  1. Sakurai M, Okamoto S, Matsumura I, Murakami S, Takizawa M, Waki M, Hirano D, Watanabe-Nakaseko R, Kobayashi N, Iino M, Mitsui H, Ishikawa Y, Takahashi N, Kawaguchi T, Suzuki R, Yamamoto K, Kizaki M, Ohnishi K, Naoe T, Akashi K; New TARGET investigators. Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line. Int J Hematol. 2020;111(6):812-825
  2. Sakurai M, Mori T, Uchiyama H, Ago H, Iwato K, Eto T, Iwasaki H, Kawata T, Takamatsu H, Yamasaki S, Takanashi M, Ichinohe T, Atsuta Y, Suzuki R. Outcome of stem cell transplantation for Waldenström's macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group. Ann Hematol. 2020;99(7):1635-1642
  3. Correa MEP, Cheng KKF, Chiang K, Kandwal A, Loprinzi CL, Mori T, Potting C, Rouleau T, Toro JJ, Ranna V, Vaddi A, Peterson DE, Bossi P, Lalla RV, Elad S. Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2020;28(5):2449-2456
  4. Abe R, Mori T, Tanigawa T, Koda Y, Hosoe N, Sakurai M, Kikuchi T, Kato J, Shimizu T, Ogata H, Kanai T, Sasaki A, Kameyama K, Okamoto S. Clinical characteristics and outcomes of duodenal-type follicular lymphoma. Leuk Lymphoma. 2020;61(13):3266-3268
  5. Mori T, Mikita K, Koda Y, Sakurai M, Saburi M, Hasegawa N, Kato J. Seroprevalence of Toxoplasma gondii among Japanese adults with hematological diseases. Int J Hematol. 2020;112(5):755-756
  6. Sakurai M, Takemoto H, Mori T, Okamoto S, Yamazaki S. In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide. Int J Hematol. 2020;111(5):739-741
  7. Mori T, Saburi M, Hagihara M, Mori M, Yamazaki R, Kato J. Long-term remission of cryopyrin-associated periodic syndrome after allogeneic haematopoietic stem cell transplantation. Ann Rheum Dis. 2020. in press
  8. Fujita H, Sasaki T, Miyamoto T, Akutsu SN, Sato S, Mori T, Nakabayashi K, Hata K, Suzuki H, Kosaki K, Matsuura S, Matsubara Y, Amagai M, Kubo A. Premature aging syndrome showing random chromosome number instabilities with CDC20 mutation. Aging Cell. 2020;19(11):13251
  9. Nakayama H, Kato J, Kikuchi T, Okayama M, Kamiya T, Mizuno K, Shimizu T, Okamoto S, Mori T. [Systemic varicella-zoster infection during ixazomib-containing multiagent chemotherapy for multiple myeloma]. Rinsho Ketsueki. 2020;61(8):870-873
  10. Abe R, Yamane Y, Shiroshita K, Koda Y, Sakurai M, Kato J, Mori T. [Efficacy of photocatalytic air purifiers in reducing dimethyl sulfide malodor following cryopreserved peripheral blood stem cell infusion]. Rinsho Ketsueki. 2020;61(8):885-887
  11. Kikuchi T, Kato J, Koda Y, Sakurai M, Hayashi Y, Mori T. Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF-producing multiple myeloma. Ann Hematol. 2020;99(7):1667-1668
  12. Toyama T, Mori T, Kato J, Sugita K, Hasegawa N, Nakata N, Hoshino Y, Okamoto S. Disseminated Mycobacterium massiliense infection in a patient with myelodysplastic syndrome undergoing allogeneic bone marrow transplantation. Transpl Infect Dis. 2020;22(3):e13278
  13. Abe R, Kato J, Hashida R, Yamane Y, Koda Y, Kikuchi T, Shimizu T, Kohno T, Kawano F, madome KI, Inoue M, Sasaki A, Kameyama K, Mori T. [Chronic active Epstein-Barr virus infection with multiple vascular lesions successfully treated by cord blood transplantation]. Rinsho Ketsueki. 2020;61(10):1502-1507
  14. Mizuno K, Yamazaki R, Uemura T, Koda Y, Kikuchi T, Mori T. [Two serial events of delayed hemolytic transfusion reactions due to different primary immune response-induced irregular antibodies]. Rinsho Ketsueki. 2020;61(10):1482-1486
  15. Mori T, Kikuchi T, Kato J, Koda Y, Sakurai M, Kikumi O, Inose R, Murata M, Hasegawa N, Nakayama H, Yamazaki R, Okamoto S. Seasonal changes in indoor airborne fungal concentration in a hematology ward. J Infect Chemother. 2020;26(4):363-366
  16. Shiroshita K, Kikuchi T, Okayama M, Kasahara H, Kamiya T, Shimizu T, Kurose N, Masaki Y, Okamoto S. Interleukin-6-producing Intravascular Large B-cell Lymphoma with Lymphadenopathy Mimicking the Histology of Multicentric Castleman Disease. Intern Med. 2020;59(23):3061-3065
  17. Shiroshita K, Mori T, Kato J, Sakurai M, Koda Y, Abe R, Murakami K, Sumiya C, Fujita S, Yamaguchi K, Yamazaki R, Nakayama H, Suzuki S, Nakahara J, Okamoto S. Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention. Bone Marrow Transplant. 2020;55(5):939-945
  18. Ohwada C, Sakaida E, Igarashi A, Kobayashi T, Doki N, Mori T, Kato J, Koda Y, Kanamori H, Tanaka M, Tachibana T, Fujisawa S, Nakajima Y, Numata A, Toyosaki M, Aoyama Y, Onizuka M, Hagihara M, Koyama S, Kanda Y, Nakasone H, Shimizu H, Kato S, Watanabe R, Shono K, Sakai R, Saito T, Nakaseko C, Okamoto S. A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort. Biol Blood Marrow Transplant. 2020;26(1):162-170
  19. Kako S, Kanda Y, Onizuka M, Aotsuka N, Usuki K, Tachibana T, Kobayashi T, Kato J, Yano S, Shimizu H, Shono K, Tanaka M, Tsukamoto S, Mori T, Yamazaki E, Najima Y, Hangaishi A, Hoshino T, Watanabe R, Matsumoto K, Okamoto S; for Kanto Study Group for Cell Therapy (KSGCT). Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study. Am J Hematol. 2020;95(3):251-257
  20. Akizuki K, Sekine M, Kogure Y, Kameda T, Shide K, Koya J, Kamiunten A, Kubuki Y, Tahira Y, Hidaka T, Kiwaki T, Tanaka H, Sato Y, Kataoka H, Kataoka K, Shimoda K. TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia.. BMC Cancer. 2020;20(1):5
  21. Sugiyama E, Togashi Y, Takeuchi Y, Shinya S, Tada Y, Kataoka K, Tane K, Sato E, Ishii G, Goto K, Shintani Y, Okumura M, Tsuboi M, Nishikawa H. Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer. Sci Immunol. 2020;5(43):eaav3937
  22. Secardin L, Limia CEG, di Stefano A, Bonamino MH, Saliba J, Kataoka K, Rehen SK, Raslova H, Marty C, Ogawa S, Vainchenker W, Monte-Mor BDCR, Plo I. TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells. Stem Cell Res. 2020;44:101755
  23. Matsukawa T, Yamamoto T, Honda A, Toya T, Ishiura H, Mitsui J, Tanaka M, Hao A, Shinohara A, Ogura M, Kataoka K, Seo S, Kumano K, Hosoi M, Narukawa K, Yasunaga M, Maki H, Ichikawa M, Nannya Y, Imai Y, Takahashi T, Takahashi Y, Nagasako Y, Yasaka K, Mano K, Kawabe Matsukawa M, Miyagawa T, Hamada M, Sakuishi K, Hayashi T, Iwata A, Terao Y, Shimizu J, Goto J, Mori H, Kunimatsu A, Aoki S, Hayashi S, Nakamura F, Arai S, Monma K, Ogata K, Yoshida T, Abe O, Inazawa J, Toda T, Kurokawa M, Tsuji S. Clinical efficacy of hematopoietic stem cell transplantation for adult adrenoleukodystrophy. Brain Commun. 2020;2(1):fcz048
  24. Saito Y, Koya J, Araki M, Kogure Y, Shingaki S, Tabata M, McClure MB, Yoshifuji K, Matsumoto S, Isaka Y, Tanaka H, Kanai K, Miyano S, Shiraishi Y, Okuno Y, Kataoka K (corresponding). Landscape and function of multiple mutations within individual oncogenes. Nature. 2020;582(7810):95-99
  25. Ochi Y, Kon A, Sakata T, Nakagawa MM, Nakazawa N, Kakuta M, Kataoka K, Koseki H, Nakayama M, Morishita D, Tsuruyama T, Saiki R, Yoda A, Okuda R, Yoshizato T, Yoshida K, Shiozawa Y, Nannya Y, Kotani S, Kogure Y, Kakiuchi N, Nishimura T, Makishima H, Malcovati L, Yokoyama A, Takeuchi K, Sugihara E, Sato TA, Sanada M, Takaori-Kondo A, Cazzola M, Kengaku M, Miyano S, Shirahige K, Suzuki HI, Ogawa S. Combined Cohesin-Runx1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic Syndromes. Cancer Discov. 2020;10(6):836-853
  26. Jo T, Nishikori M, Kogure Y, Arima H, Sasaki K, Sasaki Y, Nakagawa T, Iwai F, Momose S, Shiraishi A, Kiyonari H, Kagaya N, Onuki T, Shin-Ya K, Yoshida M, Kataoka K, Ogawa S, Iwai K, Takaori-Kondo A. LUBAC accelerates B-cell lymphomagenesis by conferring B cells resistance to genotoxic stress. Blood. 2020;136(6):684-697
  27. Yamashita D, Shimada K, Kohno K, Kogure Y, Kataoka K, Takahara T, Suzuki Y, Satou A, Sakakibara A, Nakamura S, Asano N, Kato S. PD-L1 expression on tumor or stromal cells of nodal cytotoxic T-cell lymphoma: A clinicopathological study of 50 cases. Pathol Int. 2020;70(8):513-522
  28. Sekiguchi M, Seki M, Kawai T, Yoshida K, Yoshida M, Isobe T, Hoshino N, Shirai R, Tanaka M, Souzaki R, Watanabe K, Arakawa Y, Nannya Y, Suzuki H, Fujii Y, Kataoka K, Shiraishi Y, Chiba K, Tanaka H, Shimamura T, Sato Y, Sato-Otsubo A, Kimura S, Kubota Y, Hiwatari M, Koh K, Hayashi Y, Kanamori Y, Kasahara M, Kohashi K, Kato M, Yoshioka T, Matsumoto K, Oka A, Taguchi T, Sanada M, Tanaka Y, Miyano S, Hata K, Ogawa S, Takita J. Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets. NPJ Precis Oncol. 2020;4:20
  29. Ito J, Nakano Y, Shima H, Miwa T, Kogure Y, Isshiki K, Yamazaki F, Oishi Y, Morimoto Y, Kataoka K, Okita H, Hirato J, Ichimura K, Shimada H. Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion. Brain Tumor Pathol. 2020;37(3):105-110
  30. Yoshifuji K, Kataoka K (corresponding). [Genetic alterations and lymphoma]. Rinsho Ketsueki. 2020;61(5):503-509
  31. Yasuda T, Sanada M, Nishijima D, Kanamori T, Iijima Y, Hattori H, Saito A, Miyoshi H, Ishikawa Y, Asou N, Usuki K, Hirabayashi S, Kato M, Ri M, Handa H, Ishida T, Shibayama H, Abe M, Iriyama C, Karube K, Nishikori M, Ohshima K, Kataoka K, Yoshida K, Shiraishi Y, Goto H, Adachi S, Kobayashi R, Kiyoi H, Miyazaki Y, Ogawa S, Kurahashi H, Yokoyama H, Manabe A, Iida S, Tomita A, Horibe K. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study. Cancer Sci. 2020;111(9):3367-3378
  32. Kataoka K, Koya J. Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma. J Clin Exp Hematop. 2020;60(3):66-72
  33. Fukumoto K, Sakata-Yanagimoto M, Fujisawa M, Sakamoto T, Miyoshi H, Suehara Y, Nguyen TB, Suma S, Yanagimoto S, Shiraishi Y, Chiba K, Bouska A, Kataoka K, Ogawa S, Iqbal J, Ohshima K, Chiba S. VAV1 mutations contribute to development of T-cell neoplasms in mice. Blood. 2020;136(26):3018-3032
  34. Ueno H, Yoshida K, Shiozawa Y, Nannya Y, Iijima-Yamashita Y, Kiyokawa N, Shiraishi Y, Chiba K, Tanaka H, Isobe T, Seki M, Kimura S, Makishima H, Nakagawa MM, Kakiuchi N, Kataoka K, Yoshizato T, Nishijima D, Deguchi T, Ohki K, Sato A, Takahashi H, Hashii Y, Tokimasa S, Hara J, Kosaka Y, Kato K, Inukai T, Takita J, Imamura T, Miyano S, Manabe A, Horibe K, Ogawa S, Sanada M. Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia. Blood Adv. 2020;4(20):5165-5173

学会発表

  1. 安部 涼平、森 毅彦、加藤 淳、菊池 拓、甲田 祐也、櫻井 政寿、山口健太郎、岡本真一郎. 造血器疾患に併発した血流感染症におけるプレセプシンの診断的有用性の検討. 第42回日本造血・免疫細胞療法学会(ポスター、2020年3月6日、東京)
  2. 甲田 祐也、加藤 淳、山口健太郎、水野 洸太、安部 涼平、櫻井 政寿、岡本真一郎、森 毅彦. 同種造血幹細胞移植後 HHV-6 脳炎が再発した 1 例. 第42回日本造血・免疫細胞療法学会(ポスター、2020年3月6日、東京)
  3. 城下 郊平、森 毅彦、山口健太郎、安部 涼平、甲田 祐也、櫻井 政寿、加藤 淳、岡本真一郎. 同種造血幹細胞移植後のニューモシスチス肺炎予防のための移植前介入の有用性. 第42回日本造血・免疫細胞療法学会(ポスター、2020年3月6日、東京)
  4. 加藤 淳、櫻井 政寿、中山 瞳、甲田 祐也、安部 涼平、山口健太郎、水野 洸太、岡本真一郎、森 毅彦. 移植後2年で自然寛解したABO型不適合造血幹細胞移植後の赤芽球癆の一例. 第42回日本造血・免疫細胞療法学会(ポスター、2020年3月6日、東京)
  5. 黒澤 彩子、山口 拓洋、森 文子、松浦 朋子、森 毅彦、金森 平和、近藤 忠一、梅本由香里、後藤 秀樹、吉岡 聡、町田真一郎、佐藤 貴彦、片山 雄太、加藤せい子、鐘野 勝洋、水野 石一、藤原慎一郎、河野 彰夫、高橋 都、福田 隆浩. 同種造血幹細胞移植後の就労に関する実態調査 ―同種移植サバイバーにおける離職・休職に関する検討―. 第42回日本造血・免疫細胞療法学会(一般口演、2020年3月6日、東京)
  6. 森 文子、黒澤 彩子、山口 拓洋、松浦 朋子、森 毅彦、金森 平和、近藤 忠一、梅本由香里、後藤 秀樹、吉岡 聡、町田真一郎、佐藤 貴彦、片山 雄太、加藤せい子、鐘野 勝洋、水野 石一、藤原慎一郎、河野 彰夫、高橋 都、福田 隆浩. 同種造血幹細胞移植後患者の就労に関する実態調査―移植後 1 年時の就労状況と影響要因―. 第42回日本造血・免疫細胞療法学会(看護一般口演、2020年3月6日、東京)
  7. 網藏 崇人、森 毅彦、加藤 淳、甲田 祐也、岡本真一郎. 同種造血幹細胞移植後のトキソプラズマ症発症率の検討. 第42回日本造血・免疫細胞療法学会(ポスター、2020年3月7日、東京)
  8. 大西 康、森 毅彦、山﨑 宏人、竹中 克斗、山口 博樹、土岐 典子、内田 直之、小澤 幸泰、太田 秀一、鬼塚 真仁、一戸 辰夫、熱田 由子. 成人再生不良性貧血に対する骨髄移植における CSA/MTX と TAC/MTX の比較. 第42回日本造血・免疫細胞療法学会(一般口演、2020年3月7日、東京)
  9. 山崎 理絵、森 毅彦、李 天成、鈴木 哲朗、中山 瞳、加藤 淳、櫻井 政寿、甲田 祐也、安部 涼平、岡本真一郎. 同種造血幹細胞移植後の BK polyomavirus 感染症とウイルス特異抗体の関連性の検討. 第42回日本造血・免疫細胞療法学会(一般口演、2020年3月7日、東京)
  10. 櫻井 政寿、森 毅彦、白鳥 聡一、吾郷 浩厚、内田 直之、小林 光、諫田 淳也、福田 隆浩、熱田 由子、近藤 英生. 自家移植後再発濾胞性リンパ腫に対する同種移植の成績. 第42回日本造血・免疫細胞療法学会(一般口演、2020年3月7日、東京)
  11. 清水 里紗、鈴木 律朗、杉尾 康浩、吉岡 聡、澤 正史、福田 隆浩、森 毅彦、田中 淳司、熱田 由子、近藤 英生. 再発・難治びまん性大細胞型 B 細胞性リンパ腫に対する大量化学療法/自家末梢血幹細胞 移植の後方視的検討. 第42回日本造血・免疫細胞療法学会(一般口演、2020年3月7日、東京)
  12. 立花 崇孝、近藤 健、内田 直之、土岐 典子、高田 覚、高橋 聡、矢野 真吾、森 毅彦、河野 彰夫、木村 貴文、福田 隆浩、熱田 由子、長村-井上登紀子. 慢性骨髄性白血病同種移植における BCR-ABL 遺伝子変異の予後的意義. 第42回日本造血・免疫細胞療法学会(一般口演、2020年3月7日、東京)
  13. 仲宗根秀樹、神田 善伸、森 毅彦、鬼塚 真仁、佐倉 徹、藤原慎一郎、堺田惠美子、横田 朗、青墳 信之、萩原 真紀、塚田 信弘、八田 善弘、臼杵 憲祐、中世古玲子、後藤 守孝、藤澤 信、矢野 真吾、高橋 聡、金森 平和、岡本真一郎. Ph 陽性白血病に対する血液再発予防目的 TKI 中止の検証. 第42回日本造血・免疫細胞療法学会(一般口演、2020年3月7日、東京)
  14. 藤本 亜弓、鈴木 律朗、折原 勝己、飯田美奈子、山下 卓也、長藤 宏司、金森 平和、小寺 良尚、宮村 耕一、岡本真一郎、日野 雅之. 本邦における非血縁者間末梢血幹細胞採取と骨髄採取のドナーへの影響に関する多施設前向き観察研究. 第42回日本造血・免疫細胞療法学会(一般口演、2020年3月7日、東京)
  15. 櫻井政寿、加藤淳、甲田祐也、安部涼平、山口健太郎、水野洸太、森毅彦. 同種造血幹細胞移植後閉塞性細気管支炎において拘束性換気障害が予後に与える影響. 第117回日本内科学会総会(ポスター、2020年4月10日、東京)
  16. 加藤淳、安部涼平、 甲田祐也、山口健太郎、水野洸太、櫻井政寿、岡本真一郎、上蓑義典、森毅彦. 同種造血幹細胞移植後の中枢神経合併症におけるFilmArray髄膜炎/脳炎パネルの有用性について. 第117回日本内科学会総会(ポスター、2020年4月10日、東京)
  17. 山﨑理絵、森毅彦、加藤淳、岡本宏明、長谷川雄一、櫻井政寿、中山瞳、五十嵐靖宏、松橋博子、鳥海綾子、浅尾裕美子、桑原靖子、女ヶ沢遥、弥永侑子、上村知恵、岡本真一郎、田野崎隆二. 同種造血幹細胞移植後に輸血製剤由来のHEV感染症による肝機能障害をきたした一例. 第68回日本輸血・細胞治療学会学術総会(誌上開催)
  18. 木暮泰寛、片岡圭亮. ATLの全ゲノム解析. 第93回日本生化学会大会(一般口演、2020年9月16日、Web)
  19. 田畑 真梨子、佐藤 悠佑、木暮 泰寛、Marni B. McClure、斎藤優樹、新垣 清登、吉藤 康太、古屋 淳史、河野 隆志、白石 友一、久米 春喜、片岡 圭亮. 遺伝性淡明細胞型腎細胞癌における腫瘍内または腫瘍間の遺伝的、免疫的不均一性. 第79回日本癌学会学術総会(シンポジウム、2020年10月1日、広島)
  20. 木暮 泰寛、亀田 拓郎、古屋 淳史、野坂 生郷、今泉 芳孝、斎藤優樹、MarniB. McClure、田畑 真梨子、高折 晃史、宮崎 泰司、松岡 雅雄、石塚 賢治、小川 誠司、下田 和哉、片岡 圭亮. ATLの全ゲノム解析. 第79回日本癌学会学術総会(シンポジウム、2020年10月2日、広島)
  21. 古屋 淳史、斎藤 優樹1、亀田 拓郎、木暮 泰寛、Marni B.McClure、新垣 清登、吉藤 康太、田畑 真梨子、下田和哉、片岡 圭亮. マルチオミクス単一細胞解析による HTLV-1 感染状態および ATL における細胞動態の網羅的解明. 第79回日本癌学会学術総会(シンポジウム、2020年10月2日、広島)
  22. 昆 彩奈、中川 正宏、稲垣 良作、片岡 圭亮、越智 陽太郎、牧島 秀樹、中山 学、古関 明彦、南谷 泰仁、小川 誠司. 骨髄異形成症候群における新規 DDX41 胚細胞変異・体細胞変異の機能解析. 第79回日本癌学会学術総会(一般口演、2020年10月3日、広島)
  23. Marni B. McClure, Yuki Saito, Yasunori Kogure, Keisuke Kataoka. Genetic mechanisms underlying oncogenic metabolic switch revealed by pan-cancer multi-omics analysis. 第79回日本癌学会学術総会 (一般口演、2020年10月3日、広島)
  24. 福本 浩太、坂田 麻実子、藤澤 学、三好 寛明、末原 泰人、Nguyen B Tran、白石 友一、千葉 健一、片岡 圭亮、小川 誠司、大島 孝一、千葉 滋. VAV1 変異トランスジェニックマウスにおける T 細胞性腫瘍の発生. 第79回日本癌学会学術総会 (一般口演、2020年10月3日、広島)
  25. 片岡圭亮. がん分子病態の遺伝学的解明. 第79回日本癌学会学術総会 (受賞講演、2020年10月3日、広島)
  26. Kota Fukumoto,Mamiko Sakata-Yanagimoto,Manabu Fujisawa, Tatsuhiro Sakamoto ,Hiroaki Miyoshi,Yasuhito Suehara,Nguyen Tran, Sakurako Suma,Yuichi Shiraishi ,Kenichi Chiba,Keisuke Kataoka, Seishi Ogawa,Koichi Ohshima,Shigeru Chiba. VAV1 mutations contribute to development of T-cell neoplasms in mice. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  27. Ayako Kamiunten,Daisuke Morishita,Takuro Kameda, Yasunori Kogure,Kotaro Shide,Yuki Tahira,Yasuhito Nannya, Akinori Yoda,Keiichi Akizuki Masaaki Sekine,Tomonori Hidaka, Yoko Kubuki,Akio Mizutani,Midori Sugiyama,Yasuyoshi Arikawa, Hiroshi Miyake,Keisuke Kataoka,Seishi Ogawa,Kazuya Shimoda. Development of MALT1 inhibitor and its effect on ATL. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  28. Yuji Kumade,Yasunori Kogure,Suguru Fukuhara, Hirokazu Kariyazono,Sumito Shingaki,Kota Yoshifuji,Yuki Saito, Mariko Tabata,Junji Koya,Shinji Kohsaka,Yuichi Shiraishi, Takashi Kono,Hiroyuki Mano,Seishi Ogawa,Koji Izutsu,Keisuke Kataoka. Development of a comprehensive genomic profiling assay for hematological malignancies. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  29. Yasunori Kogure,Takuro Kameda,Junji Koya,Ayako Kamiunten, Kotaro Shide,Tomonori Hidaka,Yoko Kubuki,Makoto Yoshimitsu, Kisato Nosaka,Yoshitaka Imaizumi,Mizuki Watanabe,Yuki Saito, Marni B. McClure,Mariko Tabata,Sumito Shingaki,Kota Yoshifuji, Yuichi Shiraishi,Michihiro Hidaka,Atae Utsunomiya,Juan Carlos Ramos, Tatsuhiro Shibata,Akifumi Takaori,Yasushi Miyazaki,Masao Matsuoka, Kenji Ishitsuka,Seishi Ogawa,B. Hilda Ye,Kazuya Shimoda, Keisuke Kataoka. Whole-genome analysis of adult T-cell leukemia/lymphoma. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  30. June Takeda,Kenichi Yoshida,Akinori Yoda,Yasuhito Nannya, Leeyung Shih,Yotaro Ochi,Yuichi Shiraishi,Cassandra Kerr,Yasunobu Nagata,Toshiyuki Kitano,Akira Hangaishi,Ken Ishiyama,Hisashi Tsurumi,Yasushi Miyazaki,Nobuhiro Hiramoto,Takayuki Ishikawa, Masahiro Nakagawa ,Akifumi Takaori,Shigeru Chiba ,Hideyuki Nakazawa, Mingchung Kuo,Keisuke Kataoka,Ryunosuke Saiki,Masashi Sanada, Kensuke Usuki,Shuichi Miyawaki ,Satoru Miyano,Jaroslaw Maciejewski, Hideki Makishima,Seishi Ogawa . JAK STAT pathway is a promising therapeutic target in acute erythroid leukemia. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  31. Suguru Fukuhara,Yasunori Kogure,Yuji Kumade,Hirokazu Kariyazono,Akiko Maeshima,Hiromichi Matsushita,Masanaka Sugiyama,Chitose Ogawa,Yoshihiro Inamoto,Takahiro Fukuda,Masato Sugano,Nobuhiko Yamauchi, Yosuke Minami,Teruhiko Yoshida,Kota Yoshifuji,Sumito Shingaki, Junji Koya,Yuichi Shiraishi,Seishi Ogawa,Keisuke Kataoka,Koji Izutsu. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  32. 片岡圭亮. 先端ゲノム技術を用いた ATL 分子病態の解明. 第82回日本血液学会学術集会(一般口演、2020年10月10日、Online)
  33. Masatoshi Sakurai,Shinichiro Okamoto. Development of chemically fine-tuned ex vivo human hematopoietic stem cell expansion protocol. 第82回日本血液学会学術集会(一般口演、2020年10月10日、Online)
  34. Masamitsu Yanada, Takahiro Fukuda, Masatsugu Tanaka, Shuichi Ota, Takashi Toya, Takehiko Mori, Naoyuki Uchida, Yukiyasu Ozawa, Hirohisa Nakamae, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shingo Yano. Long-term results of reduced-intensity conditioning allogeneic HCT for older patients with AML. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  35. Hiroyoshi Kunimoto, Yumi Fukuchi, Koichi Murakami, Junji Ikeda, Hiroshi Teranaka, Ikuma Kato, Takuya Miyazaki, Makiko Enaka, Takayuki Mitsuhashi, Etsuko Yamazaki, Kaori Kameyama, Mitsuru Murata, Shinichiro Okamoto, Hideaki Nakajima. Establishment of high-risk MDS/AML cell line and xenograft model harboring t(3;3) and monosomy 7. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  36. Hideki Nakasone, Yoshinobu Kanda, Takehiko Mori, Makoto Onizuka, Toru Sakura, Shinichiro Fujiwara, Emiko Sakaida, Akira Yokota, Nobuyuki Aotsuka, Maki Hagihara, Nobuhiro Tsukada, Yoshihiro Hatta, Kensuke Usuki, Reiko Nakaseko, Moritaka Gotoh, Shin Fujisawa, Shingo Yano, Satoshi Takahashi, Heiwa Kanamori, Shinichiro Okamoto. Stop TKI after allogeneic HCT for Ph+ leukemia in the real world. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  37. Takahiro Kamiya, Masatoshi Sakurai, Taku Kikuchi, Mikio Okayama, Kota Mizuno, Kentaro Yamaguchi, Ryohei Abe, Yuya Koda, Jun Kato, Takehiko Mori. Evaluation of antiemetic efficacy of ondansetron for ESHAP therapy. 第82回日本血液学会学術集会(一般口演、2020年10月10日、Online)
  38. Hirohiko Shibayama, Mitsuhiro Itagaki, Hiroshi Handa, Akihiro Yokoyama, Morio Sawamura, Satoru Kosugi, Koichiro Minauchi, Daisuke Nakamura, Yutaka Shimazu, Isamu Sugiura, Shinichi Fuchida, Masaki Iino, Takayuki Shimizu, Yukiyoshi Moriuchi, Kohtaro Toyama, Kinuko Mitani, Yutaka Tsukune, Akiko Kada, Hideto Tamura, Masahiro Abe, Hiromi Iwasaki, Junya Kuroda, Hiroyuki Takamatsu, Kazutaka Sunami, Masahiro Kizaki, Tadao Ishida, Toshiki Saito, Itaru Matsumura, Koichi Akashi, Shinsuke Iida. Patient demographics in a prospective observational study of plasma cell neoplasms in Japan. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  39. Shinya Fujita, Masatoshi Sakurai, Jun Kato, Yuya Koda, Kota Mizuno, Takahiro Kamiya, Kentaro Yamaguchi, Kohei Shiroshita, Mikio Okayama, Ryohei Abe, Taku Kikuchi, Takayuki Shimizu, Shinichiro Okamoto, Takehiko Mori. Impact of type of TKIs on allogeneic stem cell transplantation in patients with CML. 第82回日本血液学会学術集会(一般口演、2020年10月10日、Online)
  40. Shinichi Kako,Shunichi Kimura ,Hidenori Wada ,Yusuke Komiya ,Hideki Nakasone ,Masatoshi Sakurai ,Jun Kato ,Masatsugu Tanaka ,Eriko Fujii ,Takayoshi Tachibana ,Wataru Yamamoto ,Maki Hagihara ,Reiko Watanabe ,Akira Yokota ,Hirofumi Nakano ,Takehiko Mori ,Chiaki Nakaseko ,Heiwa Kanamori ,Yoshinobu Kanda . Treatment strategy at the decision of HSCT for MDS in the era of AZA: KSGCT prospective study. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  41. Mari Morita ,Yasuyuki Arai ,Tadakazu Kondo ,Kaito Harada ,Noriko Doki ,Takahiro Fukuda ,Jun Kato ,Shuichi Ota ,Yukiyasu Ozawa ,Tatsuo Ichinohe ,Takafumi Kimura ,Yoshiko Atsuta ,Shinichi Kako . High non-relapse mortality in CBT for adult ALL after conditioning with medium-dose VP16/CY/TBI. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  42. Kota Mizuno,Masatoshi Sakurai,Jun Kato,Kentaro Yamaguchi,Ryohei Abe,Yuya Koda,Takehiko Mori. Factor analysis of efficacy of letermovir in preventing CMV reactivation after allogeneic SCT. 第82回日本血液学会学術集会(一般口演、2020年10月10日、Online)
  43. Goichi Yoshimoto ,Yasuo Mori ,Akihiko Numata ,Koji Kato ,Yuya Koda ,Masatoshi Sakurai ,Jun Kato ,Takehiko Mori ,Toshihiro Miyamoto ,Katsuto Takenaka ,Koichi Akashi . Clinical utility of real-time PCR for CMV monitoring in hematopoietic cell transplantation patients. 第82回日本血液学会学術集会(一般口演、2020年10月10日、京都)
  44. Hitomi Nakayama ,Rie Yamazaki ,Jun Kato ,Yuya Koda ,Masatoshi Sakurai ,Kohei Shiroshita ,Shinya Fujita ,Kentaro Yamaguchi ,Kota Mizuno ,Takehiko Mori . Impact of CD134-positive T cells on HHV-6 reactivation after allogeneic stem cell transplantation. 第82回日本血液学会学術集会(一般口演、2020年10月10日、Online)
  45. Jun-Ichi Nishimura ,Shinji Nakao ,Ken Ishiyama ,Kensuke Usuki ,Yuji Yonemura ,Takayuki Ikezoe ,Michihiro Uchiyama ,Yasuo Mori ,Tetsuya Fukuda ,Masaya Okada ,Shinichiro Fujiwara ,Hideyoshi Noji ,Scott Rottinghaus ,Rasha Aguzzi ,Jun Yokosawa ,Yuzuru Kanakura ,Shinichiro Okamoto . Results of phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in Japanese patients with PNH. 第82回日本血液学会学術集会(ポスター、2020年10月10日、京都)
  46. Taku Kikuchi,Jun Kato,Kota Mizuno,Takahiro Kamiya,Kentaro Yamaguchi,Kohei Shiroshita,Shinya Fujita,Mikio Okayama,Ryohei Abe,Yuya Koda,Shinichiro Okamoto,Takehiko Mori. Outcome of first autologous hematopoietic stem cell transplantation for multiple myeloma. 第82回日本血液学会学術集会(ポスター、2020年10月10日、Online)
  47. Rie Yamazaki ,Jun Kato ,Tian Li ,Tetsuro Suzuki ,Hitomi Nakayama ,Ryohei Abe ,Yuya Koda ,Masatoshi Sakurai ,Takehiko Mori . Relationship between specific antibody and BKPyV reactivation after allo-HSCT. 第82回日本血液学会学術集会(ポスター、2020年10月10日、Online)
  48. Ayana Kon,Masahiro Nakagawa,Ryosaku Inagaki,Keisuke Kataoka,Yotaro Ochi,Hideki Makishima,Manabu Nakayama,Haruhiko Koseki,Yasuhito Nannya,Seishi Ogawa. The functional effect of compound DDX41 germline and somatic R525H mutations in myeloid malignancies. 第82回日本血液学会学術集会(プレナリーセッション、2020年10月11日、京都)
  49. Junji Koya,Yuki Saito,Takuro Kameda,Yasunori Kogure, Marni McClure,Sumito Shingaki,Kota Yoshifuji,Mariko Tabata, Ayako Kamiunten,Kotaro Shide,Kazuya Shimoda,Keisuke Kataoka. Dissecting multicellular ecosystems of HTLV-1 infection and ATL by multi-omics single cell analysis. 第82回日本血液学会学術集会(プレナリーセッション、2020年10月11日、京都)
  50. Shintaro Watanuki ,Hiroshi Kobayashi ,Yuki Sugiura,Yuriko Sorimachi ,Masamichi Yamamoto ,Makoto Suematsu,Shinichiro Okamoto ,Keiyo Takubo . Integrative analysis reveals significance of metabolic programs of aged hematopoietic stem cells. 第82回日本血液学会学術集会(プレナリーセッション、2020年10月11日、京都)
  51. Junya Kanda ,Naoshi Sugimoto ,Sou Nakamura ,Toshiyuki Kitano,Masakatsu Hishizawa,Tadakazu Kondo,Shin Shimizu,Akiko Shigemasa,Hideyo Hirai,Manabu Minami ,Naohide Watanabe,Masayuki Nogawa ,Makoto Handa ,Shinichiro Okamoto ,Yoshihiko Tani,Koji Eto ,Akifumi Takaori . An interim report of the clinical trial of autologous iPSC-derived platelets (iPLAT1). 第82回日本血液学会学術集会(プレナリーセッション、2020年10月11日、京都)

2019年

  1. Nakayama H, Yamazaki R, Kato J, Koda Y, Sakurai M, Abe R, Watanuki S, Sumiya C, Shiroshita K, Fujita S, Yamaguchi K, Okamoto S, Mori T. HHV-6 reactivation evaluated by digital PCR and its association with dynamics of CD134-positive T cells after allogeneic hematopoietic stem cell transplantation. J Infect Dis 2019;doi: 10.1093/infdis/jiz237. [Epub ahead of print]
  2. Sakurai M, Karigane D, Kasahara H, Tanigawa T, Ishida A, Murakami H, Kikuchi M, Kohashi S. Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma. Ann Hematol. 2019;98:
  3. Sakurai M, Kikuchi T, Karigane D, Kasahara H, Matsuki E, Hashida R, Yamane Y, Abe R, Koda Y, Toyama T, Kato J, Shimizu T, Yokoyama Y, Suzuki S, Nakamura T, Okamoto S, Mori T. Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia. Int J Hematol. 2019;109:
  4. Sakurai M, Jang JH, Chou WC, Kim JS, Wilson A, Nishimura JI, Chiou TJ, Kanakura Y, Lee JW, Okamoto S. Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria. Int J Hematol. 2019;110:
  5. Keiichi Tozawa, Yukako Ono-Uruga, Masaki Yazawa, Taisuke Mori, Mitsuru Murata, Shinichiro Okamoto, Yasuo Ikeda, Yumiko Matsubara. Megakaryocytes and platelets from a novel human adipose tissue–derived mesenchymal stem cell line. Blood. 2019;133(7):633-643
  6. Aiko Ishikawa, Yohei Otaka, Michiyo Kamisako, Tetsuya Suzuki, Chieko Miyata, Tetsuya Tsuji, Hideo Matsumoto, Jun Kato, Takehiko Mori, Shinichiro Okamoto, Meigen Liu. Factors affecting lower limb muscle strength and cardiopulmonary fitness after allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2019;27(5):1793-1800
  7. Yamazaki R, Kato J, Koda Y, Sakurai M, Tozawa K, Okayama M, Nakayama H, Watanuki S, Kikuchi T, Hasegawa N, Okamoto S, Mori T. Impact of immunoglobulin G2 subclass level on late-onset bacterial infection after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2019;21(3):e13086
  8. Shimizu R, Takeuchi M, Sakaida E, Ohwada C, Toyosaki M, Machida S, Onizuka M, Shono K, Onoda M, Saito T, Yano S, Tanaka M, Fujisawa S, Mori T, Usuki K, Takahashi S, Kanamori H, Nakaseko C, Okamoto S. Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation. Ann Hematol 2019;98(7):1781-1783
  9. Shimizu H, Doki N, Kanamori H, Sakura T, Mori T, Machida S, Takahashi S, Ohwada C, Fujisawa S, Yano S, Hagihara M, Kanda Y, Onoda M, Gotoh M, Kako S, Taguchi J, Usuki K, Kawai N, Aotsuka N, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant. Bone Marrow Transplant. 2019;doi: 10.1038/s41409-019-0585-2. [Epub ahead of print]
  10. Nishiwaki S, Miyamura K, Kanda Y, Takanashi M, Uchida N, Fukuda T, Ikegame K, Ohashi K, Eto T, Ozawa Y, Shiratori S, Iwato K, Matsuoka KI, Hidaka M, Ichinohe T, Atsuta Y, Kodera Y, Okamoto S. A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan. Bone Marrow Transplant. 2019;doi: 10.1038/s41409-019-0542-0. [Epub ahead of print]
  11. Tachibana T, Ishizaki T, Takahashi S, Najima Y, Kimura SI, Sakaida E, Onizuka M, Mori T, Fujisawa S, Fujiwara SI, Saito T, Hagihara M, Aotsuka N, Gotoh M, Usuki K, Tsukada N, Kanda J, Kanamori H, Kanda Y, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis. Bone Marrow Transplant. 2019;doi: 10.1038/s41409-019-0689-8
  12. Kikuchi T, Arai M, Koda Y, Kato J, Shimizu T, Katano H, Fujii-Nishimura Y, Sakamoto M, Ebinuma H, Nakamoto N, Kanai T, Okamoto S, Mori T. Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2019;21(4):e13121
  13. Karigane D, Kikuchi T, Sakurai M, Kato J, Yamane Y, Hashida R, Abe R, Hatano M, Hasegawa N, Wakayama M, Shibuya K, Okamoto S, Mori T Invasive hepatic mucormycosis: A case report and review of the literature. J Infect Chemother. 2019;25(1):50-53
  14. Watanuki S, Kobayashi H, Sorimachi Y, Yamamoto M, Okamoto S, Takubo K. ATP turnover and glucose dependency in hematopoietic stem/progenitor cells are increased by proliferation and differentiation. Biochem Biophys Res Commun 2019;514(1):287-294
  15. Ohwada C, Sakaida E, Igarashi A, Kobayashi T, Doki N, Mori T, Kato J, Koda Y, Kanamori H, Tanaka M, Tachibana T, Fujisawa S, Nakajima Y, Numata A, Toyosaki M, Aoyama Y, Onizuka M, Hagihara M, Koyama S, Kanda Y, Nakasone H, Shimizu H, Kato S, Watanabe R, Shono K, Sakai R, Saito T, Nakaseko C, Okamoto S. A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort. Biol Blood Marrow Transplant. 2019;doi: 10.1016/j.bbmt.2019.09.016. [Epub ahead of print]:
  16. Tanigawa T, Abe R, Kato J, Hosoe N, Ogata H, Kameyama K, Okamoto S, Mori T. Histological transformation in duodenal-type follicular lymphoma: a case report and review of the literature. Oncotarget. 2019;20(36):3424-3429
  17. Nishiwaki S, Tanaka H, Kojima H, Okamoto S. Availability of HLA-allele-matched unrelated donors: estimation from haplotype frequency in the Japanese population Bone Marrow Transplant 2019;54(2):300-303
  18. Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Matsumoto K, Aotsuka N, Goto M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S. Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis. Leukemia. 2019;doi: 10.1038/s41375-019-0494-9. [Epub ahead of print]:

2018年

  1. Okayama M, Kitabatake S, Sato M, Fujimori, Daiju Ichikawa, Matsushita M, Suto Y, Iwasaki G, Yamada T, Kiuchi F, Hirao M, Kunieda H, Osada M, Okamoto S, Hattori Y. A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress. Biochemical and Biophysical Research Communications 2018;505:787-793
  2. Sakurai M, Toyama T, Kikuchi T, Kato J, Shimizu T, Koda Y, Karigane D, Yamane Y, Abe R, Yamazaki R, Nakazato T, Nakahara T, Jinzaki M, Okamoto S, Mori T. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma. . Int J Hematol. 2018;107:194-200
  3. Okamoto S, Teshima T, Kosugi-Kanaya M, Kahata K, Kawashima N, Kato J, Mori T, Ozawa Y, Miyamura K. Extracorporeal photoperesis with TC-V in Japanese patients with steroid-resistanat chronic graft-versus-host disease. Int J Hematol. 2018;108:298-305
  4. Takanashi S, Nakazato T, Aisa Y, Ito C, Arakaki H, Osada Y, Hirano M, Mori T. The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders. Ann Hematol 2018;doi: 10.1007/s00277-018-3327-4.
  5. Fujita Y, Nakazato T, Ito C, Masuda K, Osada Y, Aisa Y, Mori T. A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment. Ann Hematol. 2018 Oct;97(10):2009-2010.
  6. Yamazaki R, Kikuchi T, Kato J, Sakurai M, Koda Y, Hashida R, Yamane Y, Abe R, Hasegawa N, Okamoto S, Mori T. Recurrent bacterial pneumonia due to immunoglobulin G2 subclass deficiency after allogeneic hematopoietic stem cell transplantation: Efficacy of immunoglobulin replacement. Transpl Infect Dis. 2018 Jun;20(3):e12863. doi: 10.1111/tid.12863.
  7. Nakazato T, Takanashi S, Hirano M, Ito C, Fujita Y, Osada Y, Aisa Y, Mori T. Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma. Ann Hematol. 2018 Aug;97(8):1489-1491.
  8. Sakurai M, Watanuki S, Kato J, Hashida R, Yamane Y, Karigane D, Mitsuhashi T, Murata M, Ueno H, Nakazato T, Okamoto S, Mori T. Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission. Intern Med. 2018;(57):3299-3302
  9. Sakurai M, Kato J, Toyama T, Hashida R, Yamane Y, Abe R, Koda Y, Kohashi S, Kikuchi T, Hayashi Y, Nukaga S, Ueda S, Fukunaga K, Okamoto S, Mori T. Successful Steroid Therapy for Lipoid Pneumonia Developing After Allogeneic Hematopoietic Stem Cell Transplant: A Case Report. Transplant Proc 2018;(50):4096-4098
  10. Kikuchi T, Arai M, Koda Y, Kato J, Shimizu T, Katano H, Fujii-Nishimura Y, Sakamoto M, Ebinuma H, Nakamoto N, Kanai T, Okamoto S, Mori T. Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2019 Aug;21(4):.e13121
  11. Karigane D, Kikuchi T, Sakurai M, Kato J, Yamane Y, Hashida R, Abe R, Hatano M, Hasegawa N, Wakayama M, Shibuya K, Okamoto S, Mori T. Invasive hepatic mucormycosis: A case report and review of the literature. J Infect Chemother. 2018;25(1):50-53. doi: 10.1016/j.jiac.2018.06.013.

2017年

  1. Sakurai M, Mori T, Karigane D, Tozawa K, Matsuki E, Shimizu T, Yokoyama K, Nakajima H, Kanda Y, Okamoto S. Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors. Int J Hematol.2015;102(3):342-8.
  2. Sumiya C, Arai Y, Takayama M, Abe Y, Hirose N, Asakura K, Nishiwaki Y, Takebayashi T. Vitamin D deficiency and lifestyle factors in the oldest old. Am J Geriatrics Soc.2017;58(11):2242-2244.
  3. Koichi Murakami, Sumiko Kohashi, Masatoshi Sakurai, Jun Kato, Takaaki Toyama, Yuya Koda, Yusuke Yamane, Risa Hashida, Ryohei Abe, Rie Yamazaki, Taku Kikuchi, Takayuki Shimizu, Shigeaki Suzuki, Naoki Hasegawa, Shinichiro Okamoto, Takehiko Mori Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis Int J Hematol.2017;106(3):436-440.
  4. Hidenori Kasahara,Taisuke Kondo, Hiroko Nakatsukasa, Shunsuke Chikuma, Minako Ito, Yutaka Kurebayashi, Takashi Sekiya, Taketo Yamada, Shinichiro Okamoto, Akihiko Yoshimura. Generation of alloantigen-specific induced-Treg stabilized by vitamin C treatment and its application for prevention of acute graft ersus host disease model. Int Immunol.2017;29(10):457-469.
  5. Mori T, Kanda Y, Takenaka K, Okamoto S, Kato J, Kanda J, Yoshimoto G, Gondo H, Doi S, Inaba M, Kodera Y. Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial. Int J Hematol.2017;105(2):206-212
  6. Arakaki H, Nakazato T, Osada Y, Ito C, Aisa Y, Mori T. Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphoma. Ann Hematol.2017;96(7):1225-1226
  7. Saburi M, Kohashi S, Kato J, Koda Y, Sakurai M, Toyama T, Kikuchi T, Karigane D, Yuda S, Yamane Y, Hashida R, Abe R, Nakazato T, Hirahashi J, Ogata M, Okamoto S, Mori T. Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation. Int J Hematol.2017;106(3):431-435.
  8. Murakami K, Kohashi S, Sakurai M, Kato J, Toyama T, Koda Y, Yamane Y, Hashida R, Abe R, Yamazaki R, Kikuchi T, Shimizu T, Suzuki S, Hasegawa N, Okamoto S, Mori T. Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis. Int J Hematol.2017;106(3):436-440.
  9. Kato J, Mori T, Suzuki T, Ito M, Li TC, Sakurai M, Yamane Y, Yamazaki R, Koda Y, Toyama T, Hasegawa N, Okamoto S. Nosocomial BK Polyomavirus infection causing hemorrhagic cystitis among patients with hematological malignancies after hematopoietic stem cell transplantation. Am J Transplant.2017;17(9):2428-2433.
  10. Yamane M, Ogawa Y, Fukui M, Kamoi M, Uchino M, Saijo-Ban Y, Kozuki N, Mukai S, Mori T, Okamoto S, Tsubota K. Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study. Eye Contact Lens.2017 doi: 10.1097/ICL.0000000000000455
  11. Namkoong H, Ishii M, Mori T, Sugiura H, Tasaka S, Sakurai M, Koda Y, Kato J, Hasegawa N, Okamoto S, Betsuyaku T. Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation. BMC Pulm Med.2017;17(1):123

2016年

  1. Sakurai M, Kasahara H, Yoshida K, Yoshimi A, Kunimoto H, Watanabe N, Shiraishi Y, Chiba K, Tanaka H, Harada Y, Harada H, Kawakita T, Kurokawa M, Miyano S, Takahashi S, Ogawa S, Okamoto S, Nakajima H. Genetic basis of myeloid transformation in familial platelet disorder/acute myeloid leukemia patients with haploinsufficient RUNX1allele. Blood Cancer J. 2016;56:e392.
  2. Karigane D, Kobayashi H, Morikawa T, Ootomo Y, Sakai M, Nagamatsu G, Kubota Y, Goda N, Matsumoto M, Nishimura EK, Soga T, Otsu K, Suematsu M, Okamoto S, Suda T, Takubo K. p38α Activates Purine Metabolism to Initiate Hematopoietic Stem/Progenitor Cell Cycling in Response to Stress. Cell Stem Cell. 2016;192:192-204.
  3. Kanda Y, Kobayashi T, Mori T, Tanaka M, Nakaseko C, Yokota A, Watanabe R, Kako S, Kakihana K, Kato J, Tanihara A, Doki N, Ashizawa M, Kimura SI, Kikuchi M, Kanamori H, Okamoto S. A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation. Bone Marrow Transplant. 2016;511:103-9.
  4. Mori T, Kato J, Sakurai M, Hashimoto N, Kohashi S, Hashida R, Saburi M, Kikuchi T, Yamane Y, Hoshino K, Okamoto S. New-onset food allergy following cord blood transplantation in adult patients. Bone Marrow Transplant. 2016;512:259-6.
  5. Mori T, Koh H, Onishi Y, Kako S, Onizuka M, Kanamori H, Ozawa Y, Kato C, Iida H, Suzuki R, Ichinohe T, Kanda Y, Maeda T, Nakao S, Yamazaki H. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling. Int J Hematol. 2016;1034:461-8
  6. Asakura T, Ishii M, Kikuchi T, Kameyama K, Namkoong H, Nakata N, Sugita K, Tasaka S, Shimizu T, Hoshino Y, Okamoto S, Betsuyaku T, Hasegawa N. Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma;A Case Report. Medicine (Baltimore). 2016;95(11).e3131
  7. Mori T, Kato J, Sakurai M, Hashimoto N, Kohashi S, Hashida R, Saburi M, Kikuchi T, Yamane Y, Hoshino K, Okamoto S New-onset food allergy following cord blood transplantation in adult patients. Bone Marrow Transplant 2016;51(2).295-296

2015年

  1. Sakurai M, Mori T, Karigane D, Tozawa K, Matsuki E, Shimizu T, Yokoyama K, Nakajima H, Kanda Y, Okamoto S. Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors. Int J Hematol.2015;1023:342-8.
  2. Kikuchi T, Mori T, Koda Y, Kohashi S, Kato J, Toyama T, Nakazato T, Aisa Y, Shimizu T, Okamoto S. Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma. Int J Hematol2015;10251:670-677.
  3. Nakayama H, Aisa Y, Ito C, Shimazaki K, Katsumata Y, Hayashi H, Nakazato T. Importance of Histologic Verification of Positive Positron Emission Tomography/Computed Tomography Findings in the Follow-Up of Patients With Malignant Lymphoma. Clinical Lymphoma & Myeloma & Leukemia.2015;1512:753–760.
  4. Kohashi S, Mori T, Hashida R, Kato J, Saburi M, Kikuchi T, Koda Y, Toyama T, Yamane Y, Yamanaka S, Okamoto S. Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogenic hematopoietic stem cell transplantation for aplastic anemia. Int J Hematol.2015;1011:102-5.
  5. Motohashi K, Fujisawa S, Onizuka M, Kako S, Sakaida E, Shono K, Tatara R, Doki N, Mori T, Sakura T, Aotsuka N, Fuji E, Tomita N, Kawai N, Saitoh T, Usuki K, Taguchi J, Watanabe R, Kobayashi S, Yano S, Kanamori H, Takahashi S, Okamoto S. Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant.2015;5011:1476-9.
  6. Yano S, Mori T, Kanda Y, Kato J, Nakaseko C, Fujisawa S, Tomita N, Sakai R, Shono K, Saitoh T, Aotsuka N, Kobayashi N, Saito T, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma. Bone Marrow Transplant.2015;5010:1299-305.
  7. Kasahara H, Mori T, Kato J, Koda Y, Kohashi S, Kikuchi T, Sakurai M, Yamane Y, Mikami S, Kameyama K, Takahashi Y, Okamoto S. Post-transplant lymphoproliferative disorder of the adrenal gland after allogeneic hematopoietic stem cell transplantation: report of two cases and literature review. Transpl Infect Dis 2015;17.909-914

片岡教授 慶應着任前業績

  1. Yamashita D, Shimada K, Kohno K, Kogure Y, Kataoka K, Takahara T, Suzuki Y, Satou A, Sakakibara A, Nakamura S, Asano N, Kato S. PD-L1 expression on tumor or stromal cells of nodal cytotoxic T-cell lymphoma: A clinicopathological study of 50 cases. Pathol Int. 2020
  2. Secardin L, Limia CEG, di Stefano A, Bonamino MH, Saliba J, Kataoka K, Rehen SK, Raslova H, Marty C, Ogawa S, Vainchenker W, Monte-Mor B, Plo I. TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells. Stem Cell Res. 2020;44:101755
  3. Saito Y, Koya J, Araki M, Kogure Y, Shingaki S, Tabata M, McClure MB, Yoshifuji K, Matsumoto S, Isaka Y, Tanaka H, Kanai T, Miyano S, Shiraishi Y, Okuno Y, Kataoka K. Landscape and function of multiple mutations within individual oncogenes. Nature. 2020;582:95-99
  4. Ochi Y, Kon A, Sakata T, Nakagawa MM, Nakazawa N, Kakuta M, Kataoka K, Koseki H, Nakayama M, Morishita D, Tsuruyama T, Saiki R, Yoda A, Okuda R, Yoshizato T, Yoshida K, Shiozawa Y, Nannya Y, Kotani S, Kogure Y, Kakiuchi N, Nishimura T, Makishima H, Malcovati L, Yokoyama A, Takeuchi K, Sugihara E, Sato TA, Sanada M, Takaori-Kondo A, Cazzola M, Kengaku M, Miyano S, Shirahige K, Suzuki HI, Ogawa S. Combined Cohesin-RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic Syndromes. Cancer Discov. 2020;10:836-853
  5. Yasuda T, Sanada M, Nishijima D, Kanamori T, Iijima Y, Hattori H, Saito A, Miyoshi H, Ishikawa Y, Asou N, Usuki K, Hirabayashi S, Kato M, Ri M, Handa H, Ishida T, Shibayama H, Abe M, Iriyama C, Karube K, Nishikori M, Ohshima K, Kataoka K, Yoshida K, Shiraishi Y, Goto H, Adachi S, Kobayashi R, Kiyoi H, Miyazaki Y, Ogawa S, Kurahashi H, Yokoyama H, Manabe A, Iida S, Tomita A, Horibe K. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study. Cancer Sci. 2020
  6. Ito J, Nakano Y, Shima H, Miwa T, Kogure Y, Isshiki K, Yamazaki F, Oishi Y, Morimoto Y, Kataoka K, Okita H, Hirato J, Ichimura K, Shimada H. Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion. Brain Tumor Pathol. 2020;37:105-110
  7. Sugiyama E, Togashi Y, Takeuchi Y, Shinya S, Tada Y, Kataoka K, Tane K, Sato E, Ishii G, Goto K, Shintani Y, Okumura M, Tsuboi M, Nishikawa H. Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer. Sci Immunol. 2020;5
  8. Akizuki K, Sekine M, Kogure Y, Kameda T, Shide K, Koya J, Kamiunten A, Kubuki Y, Tahira Y, Hidaka T, Kiwaki T, Tanaka H, Sato Y, Kataoka H, Kataoka K, Shimoda K. TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia. BMC Cancer. 2020;20:5
  9. Kakiuchi N, Yoshida K, Uchino M, Kihara T, Akaki K, Inoue Y, Kawada K, Nagayama S, Yokoyama A, Yamamoto S, Matsuura M, Horimatsu T, Hirano T, Goto N, Takeuchi Y, Ochi Y, Shiozawa Y, Kogure Y, Watatani Y, Fujii Y, Kim SK, Kon A, Kataoka K, Yoshizato T, Nakagawa MM, Yoda A, Nanya Y, Makishima H, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Sugihara E, Sato TA, Maruyama T, Miyoshi H, Taketo MM, Oishi J, Inagaki R, Ueda Y, Okamoto S, Okajima H, Sakai Y, Sakurai T, Haga H, Hirota S, Ikeuchi H, Nakase H, Marusawa H, Chiba T, Takeuchi O, Miyano S, Seno H, Ogawa S. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis. Nature. 2020;577:260-265
  10. Jo T, Nishikori M, Kogure Y, Arima H, Sasaki K, Sasaki Y, Nakagawa T, Iwai F, Momose S, Shiraishi A, Kiyonari H, Kagaya N, Onuki T, Shin-Ya K, Yoshida M, Kataoka K, Ogawa S, Iwai K, Takaori-Kondo A. LUBAC accelerates B-cell lymphomagenesis by conferring B cells resistance to genotoxic stress. Blood. 2020
  11. Sekiguchi M, Seki M, Kawai T, Yoshida K, Yoshida M, Isobe T, Hoshino N, Shirai R, Tanaka M, Souzaki R, Watanabe K, Arakawa Y, Nannya Y, Suzuki H, Fujii Y, Kataoka K, Shiraishi Y, Chiba K, Tanaka H, Shimamura T, Sato Y, Sato-Otsubo A, Kimura S, Kubota Y, Hiwatari M, Koh K, Hayashi Y, Kanamori Y, Kasahara M, Kohashi K, Kato M, Yoshioka T, Matsumoto K, Oka A, Taguchi T, Sanada M, Tanaka Y, Miyano S, Hata K, Ogawa S, Takita J. Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets. NPJ Precis Oncol. 2020;4:20
  12. Matsukawa T, Yamamoto T, Honda A, Toya T, Ishiura H, Mitsui J, Tanaka M, Hao A, Shinohara A, Ogura M, Kataoka K, Seo S, Kumano K, Hosoi M, Narukawa K, Yasunaga M, Maki H, Ichikawa M, Nannya Y, Imai Y, Takahashi T, Takahashi Y, Nagasako Y, Yasaka K, Mano KK, Matsukawa MK, Miyagawa T, Hamada M, Sakuishi K, Hayashi T, Iwata A, Terao Y, Shimizu J, Goto J, Mori H, Kunimatsu A, Aoki S, Hayashi S, Nakamura F, Arai S, Momma K, Ogata K, Yoshida T, Abe O, Inazawa J, Toda T, Kurokawa M, Tsuji S. Clinical efficacy of haematopoietic stem cell transplantation for adult adrenoleukodystrophy. Brain Communications. 2020;2
  13. Kubota Y, Uryu K, Ito T, Seki M, Kawai T, Isobe T, Kumagai T, Toki T, Yoshida K, Suzuki H, Kataoka K, Shiraishi Y, Chiba K, Tanaka H, Ohki K, Kiyokawa N, Kagawa J, Miyano S, Oka A, Hayashi Y, Ogawa S, Terui K, Sato A, Hata K, Ito E, Takita J. Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome. Cancer Sci. 2019;110:3358-3367
  14. Becker H, Greve G, Kataoka K, Mallm JP, Duque-Afonso J, Ma T, Niemoller C, Pantic M, Duyster J, Cleary ML, Schuler J, Rippe K, Ogawa S, Lubbert M. Identification of enhancer of mRNA decapping 4 as a novel fusion partner of MLL in acute myeloid leukemia. Blood Adv. 2019;3:761-765
  15. Chung EY, Mai Y, Shah UA, Wei Y, Ishida E, Kataoka K, Ren X, Pradhan K, Bartholdy B, Wei X, Zou Y, Zhang J, Ogawa S, Steidl U, Zang X, Verma A, Janakiram M, Ye BH. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma. Clin Cancer Res. 2019;25:3589-3601
  16. Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronne L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas. Leukemia. 2019
  17. Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, Sato Y, Sawada G, Mimori K, Minamiguchi S, Haga H, Seno H, Miyano S, Makishima H, Muto M, Ogawa S. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565:312-317
  18. Watatani Y, Sato Y, Miyoshi H, Sakamoto K, Nishida K, Gion Y, Nagata Y, Shiraishi Y, Chiba K, Tanaka H, Zhao L, Ochi Y, Takeuchi Y, Takeda J, Ueno H, Kogure Y, Shiozawa Y, Kakiuchi N, Yoshizato T, Nakagawa MM, Nanya Y, Yoshida K, Makishima H, Sanada M, Sakata-Yanagimoto M, Chiba S, Matsuoka R, Noguchi M, Hiramoto N, Ishikawa T, Kitagawa J, Nakamura N, Tsurumi H, Miyazaki T, Kito Y, Miyano S, Shimoda K, Takeuchi K, Ohshima K, Yoshino T, Ogawa S, Kataoka K. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia. 2019;33:2867-2883
  19. Subramanian K, Dierckx T, Khouri R, Menezes SM, Kagdi H, Taylor GP, Farre L, Bittencourt A, Kataoka K, Ogawa S, Van Weyenbergh J. Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy? Int J Cancer. 2019;144:1664-1675
  20. Kotani S, Yoda A, Kon A, Kataoka K, Ochi Y, Shiozawa Y, Hirsch C, Takeda J, Ueno H, Yoshizato T, Yoshida K, Nakagawa MM, Nannya Y, Kakiuchi N, Yamauchi T, Aoki K, Shiraishi Y, Miyano S, Maeda T, Maciejewski JP, Takaori-Kondo A, Ogawa S, Makishima H. Molecular pathogenesis of disease progression in MLL-rearranged AML. Leukemia. 2018
  21. Shiozawa Y, Malcovati L, Galli A, Sato-Otsubo A, Kataoka K, Sato Y, Watatani Y, Suzuki H, Yoshizato T, Yoshida K, Sanada M, Makishima H, Shiraishi Y, Chiba K, Hellstrom-Lindberg E, Miyano S, Ogawa S, Cazzola M. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. Nat Commun. 2018;9:3649
  22. Toki T, Yoshida K, Wang R, Nakamura S, Maekawa T, Goi K, Katoh MC, Mizuno S, Sugiyama F, Kanezaki R, Uechi T, Nakajima Y, Sato Y, Okuno Y, Sato-Otsubo A, Shiozawa Y, Kataoka K, Shiraishi Y, Sanada M, Chiba K, Tanaka H, Terui K, Sato T, Kamio T, Sakaguchi H, Ohga S, Kuramitsu M, Hamaguchi I, Ohara A, Kanno H, Miyano S, Kojima S, Ishiguro A, Sugita K, Kenmochi N, Takahashi S, Eto K, Ogawa S, Ito E. De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome. Am J Hum Genet. 2018;103:440-447
  23. Taoka K, Arai S, Kataoka K, Hosoi M, Miyauchi M, Yamazaki S, Honda A, Aixinjueluo W, Kobayashi T, Kumano K, Yoshimi A, Otsu M, Niwa A, Nakahata T, Nakauchi H, Kurokawa M. Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate. Sci Rep. 2018;8:15855
  24. Shah UA, Chung EY, Giricz O, Pradhan K, Kataoka K, Gordon-Mitchell S, Bhagat TD, Mai Y, Wei Y, Ishida E, Choudhary GS, Joseph A, Rice R, Gitego N, Parrish C, Bartenstein M, Goel S, Mantzaris I, Shastri A, Derman O, Binder A, Gritsman K, Kornblum N, Braunschweig I, Bhagat C, Hall J, Graber A, Ratner L, Wang Y, Ogawa S, Verma A, Ye BH, Janakiram M. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood. 2018;132:1507-1518
  25. Miyauchi M, Koya J, Arai S, Yamazaki S, Honda A, Kataoka K, Yoshimi A, Taoka K, Kumano K, Kurokawa M. ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells. Stem Cell Reports. 2018;10:1115-1130
  26. Sakai H, Hosono N, Nakazawa H, Przychodzen B, Polprasert C, Carraway HE, Sekeres MA, Radivoyevitch T, Yoshida K, Sanada M, Yoshizato T, Kataoka K, Nakagawa MM, Ueno H, Nannya Y, Kon A, Shiozawa Y, Takeda J, Shiraishi Y, Chiba K, Miyano S, Singh J, Padgett RA, Ogawa S, Maciejewski JP, Makishima H. A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia. Leukemia. 2018;32:839-843
  27. Kataoka K, Iwanaga M, Yasunaga JI, Nagata Y, Kitanaka A, Kameda T, Yoshimitsu M, Shiraishi Y, Sato-Otsubo A, Sanada M, Chiba K, Tanaka H, Ochi Y, Aoki K, Suzuki H, Shiozawa Y, Yoshizato T, Sato Y, Yoshida K, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Shide K, Kubuki Y, Hidaka T, Nakamaki T, Ishiyama K, Miyawaki S, Ishii R, Nureki O, Tobinai K, Miyazaki Y, Takaori-Kondo A, Shibata T, Miyano S, Ishitsuka K, Utsunomiya A, Shimoda K, Matsuoka M, Watanabe T, Ogawa S. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma. Blood. 2018;131:215-225
  28. Aoki K, Nakamura H, Suzuki H, Matsuo K, Kataoka K, Shimamura T, Motomura K, Ohka F, Shiina S, Yamamoto T, Nagata Y, Yoshizato T, Mizoguchi M, Abe T, Momii Y, Muragaki Y, Watanabe R, Ito I, Sanada M, Yajima H, Morita N, Takeuchi I, Miyano S, Wakabayashi T, Ogawa S, Natsume A. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro Oncol. 2018;20:66-77
  29. Isobe T, Seki M, Yoshida K, Sekiguchi M, Shiozawa Y, Shiraishi Y, Kimura S, Yoshida M, Inoue Y, Yokoyama A, Kakiuchi N, Suzuki H, Kataoka K, Sato Y, Kawai T, Chiba K, Tanaka H, Shimamura T, Kato M, Iguchi A, Hama A, Taguchi T, Akiyama M, Fujimura J, Inoue A, Ito T, Deguchi T, Kiyotani C, Iehara T, Hosoi H, Oka A, Sanada M, Tanaka Y, Hata K, Miyano S, Ogawa S, Takita J. Integrated Molecular Characterization of the Lethal Pediatric Cancer Pancreatoblastoma. Cancer Res. 2018;78:865-876
  30. Kon A, Yamazaki S, Nannya Y, Kataoka K, Ota Y, Nakagawa MM, Yoshida K, Shiozawa Y, Morita M, Yoshizato T, Sanada M, Nakayama M, Koseki H, Nakauchi H, Ogawa S. Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice. Blood. 2018;131:621-635
  31. Koya J, Kataoka K. More accurate prognostic prediction in diffuse large B-cell lymphoma: beyond cell-of-origin. Ann Oncol. 2018;29:2284-2286
  32. Kataoka K, Ogawa S. PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma. N Engl J Med. 2018;379:696
  33. Vallois D, Dupuy A, Lemonnier F, Allen G, Missiaglia E, Fataccioli V, Ortonne N, Clavert A, Delarue R, Rousselet MC, Fabiani B, Llamas-Gutierrez F, Ogawa S, Thome M, Ko YH, Kataoka K, Gaulard P, de Leval L. RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells. Haematologica. 2018;103:e360-e363
  34. Shiraishi Y, Kataoka K, Chiba K, Okada A, Kogure Y, Tanaka H, Ogawa S, Miyano S. A comprehensive characterization of cis-acting splicing-associated variants in human cancer. Genome Res. 2018;28:1111-1125
  35. Kogure Y, Kataoka K. Genetic alterations in adult T-cell leukemia/lymphoma. Cancer Sci. 2017;108:1719-1725
  36. Takagi M, Yoshida M, Nemoto Y, Tamaichi H, Tsuchida R, Seki M, Uryu K, Nishii R, Miyamoto S, Saito M, Hanada R, Kaneko H, Miyano S, Kataoka K, Yoshida K, Ohira M, Hayashi Y, Nakagawara A, Ogawa S, Mizutani S, Takita J. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor. J Natl Cancer Inst. 2017;109
  37. Takeda Y, Kataoka K, Yamagishi J, Ogawa S, Seya T, Matsumoto M. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy. Cell Rep. 2017;19:1874-1887
  38. Hirabayashi S, Seki M, Hasegawa D, Kato M, Hyakuna N, Shuo T, Kimura S, Yoshida K, Kataoka K, Fujii Y, Shiraishi Y, Chiba K, Tanaka H, Kiyokawa N, Miyano S, Ogawa S, Takita J, Manabe A. Constitutional abnormalities of IDH1 combined with secondary mutations predispose a patient with Maffucci syndrome to acute lymphoblastic leukemia. Pediatr Blood Cancer. 2017
  39. Tsuruta-Kishino T, Koya J, Kataoka K, Narukawa K, Sumitomo Y, Kobayashi H, Sato T, Kurokawa M. Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera. Oncogene. 2017;36:3300-3311
  40. Osumi T, Kato M, Ouchi-Uchiyama M, Tomizawa D, Kataoka K, Fujii Y, Seki M, Takita J, Ogawa S, Uchiyama T, Ohki K, Kiyokawa N. Blastic transformation of juvenile myelomonocytic leukemia caused by the copy number gain of oncogenic KRAS. Pediatr Blood Cancer. 2017
  41. Uryu K, Nishimura R, Kataoka K, Sato Y, Nakazawa A, Suzuki H, Yoshida K, Seki M, Hiwatari M, Isobe T, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Koh K, Hanada R, Oka A, Hayashi Y, Ohira M, Kamijo T, Nagase H, Takimoto T, Tajiri T, Nakagawara A, Ogawa S, Takita J. Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis. Oncotarget. 2017;8:107513-107529
  42. Tsujimoto SI, Nakano Y, Osumi T, Okada K, Ouchi-Uchiyama M, Kataoka K, Fujii Y, Ohki K, Seki M, Tamagawa N, Takita J, Ogawa S, Kiyokawa N, Hara J, Kato M. A Cryptic NUP214-ABL1 Fusion in B-cell Precursor Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2017
  43. Seki M, Kimura S, Isobe T, Yoshida K, Ueno H, Nakajima-Takagi Y, Wang C, Lin L, Kon A, Suzuki H, Shiozawa Y, Kataoka K, Fujii Y, Shiraishi Y, Chiba K, Tanaka H, Shimamura T, Masuda K, Kawamoto H, Ohki K, Kato M, Arakawa Y, Koh K, Hanada R, Moritake H, Akiyama M, Kobayashi R, Deguchi T, Hashii Y, Imamura T, Sato A, Kiyokawa N, Oka A, Hayashi Y, Takagi M, Manabe A, Ohara A, Horibe K, Sanada M, Iwama A, Mano H, Miyano S, Ogawa S, Takita J. Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia. Nat Genet. 2017;49:1274-1281
  44. Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Suzuki H, Nagata Y, Sato Y, Kakiuchi N, Matsuo K, Onizuka M, Kataoka K, Chiba K, Tanaka H, Ueno H, Nakagawa MM, Przychodzen B, Haferlach C, Kern W, Aoki K, Itonaga H, Kanda Y, Sekeres MA, Maciejewski JP, Haferlach T, Miyazaki Y, Horibe K, Sanada M, Miyano S, Makishima H, Ogawa S. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Blood. 2017;129:2347-2358
  45. Sumitomo Y, Koya J, Nakazaki K, Kataoka K, Tsuruta-Kishino T, Morita K, Sato T, Kurokawa M. Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia. Blood. 2016;128:1614-1624
  46. Kataoka K, Ogawa S. Novel mechanism of immune evasion involving PD-L1 in various cancers. Translational Cancer Research. 2016;5:S928-S929
  47. Mori T, Nagata Y, Makishima H, Sanada M, Shiozawa Y, Kon A, Yoshizato T, Sato-Otsubo A, Kataoka K, Shiraishi Y, Chiba K, Tanaka H, Ishiyama K, Miyawaki S, Mori H, Nakamaki T, Kihara R, Kiyoi H, Koeffler HP, Shih LY, Miyano S, Naoe T, Haferlach C, Kern W, Haferlach T, Ogawa S, Yoshida K. Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms. Leukemia. 2016;30:2270-2273
  48. Tominaga R, Katagiri T, Kataoka K, Kataoka K, Wee RK, Maeda A, Gomyo H, Mizuno I, Murayama T, Ogawa S, Nakao S. Paroxysmal nocturnal hemoglobinuria induced by the occurrence of BCR-ABL in a PIGA mutant hematopoietic progenitor cell. Leukemia. 2016;30:1208-1210
  49. Koya J, Kataoka K, Sato T, Bando M, Kato Y, Tsuruta-Kishino T, Kobayashi H, Narukawa K, Miyoshi H, Shirahige K, Kurokawa M. DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nat Commun. 2016;7:10924
  50. Kataoka K, Shiraishi Y, Takeda Y, Sakata S, Matsumoto M, Nagano S, Maeda T, Nagata Y, Kitanaka A, Mizuno S, Tanaka H, Chiba K, Ito S, Watatani Y, Kakiuchi N, Suzuki H, Yoshizato T, Yoshida K, Sanada M, Itonaga H, Imaizumi Y, Totoki Y, Munakata W, Nakamura H, Hama N, Shide K, Kubuki Y, Hidaka T, Kameda T, Masuda K, Minato N, Kashiwase K, Izutsu K, Takaori-Kondo A, Miyazaki Y, Takahashi S, Shibata T, Kawamoto H, Akatsuka Y, Shimoda K, Takeuchi K, Seya T, Miyano S, Ogawa S. Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers. Nature. 2016;534:402-406
  51. Nagata Y, Kontani K, Enami T, Kataoka K, Ishii R, Totoki Y, Kataoka TR, Hirata M, Aoki K, Nakano K, Kitanaka A, Sakata-Yanagimoto M, Egami S, Shiraishi Y, Chiba K, Tanaka H, Shiozawa Y, Yoshizato T, Suzuki H, Kon A, Yoshida K, Sato Y, Sato-Otsubo A, Sanada M, Munakata W, Nakamura H, Hama N, Miyano S, Nureki O, Shibata T, Haga H, Shimoda K, Katada T, Chiba S, Watanabe T, Ogawa S. Variegated RHOA mutations in adult T-cell leukemia/lymphoma. Blood. 2016;127:596-604
  52. Maeda T, Nagano S, Ichise H, Kataoka K, Yamada D, Ogawa S, Koseki H, Kitawaki T, Kadowaki N, Takaori-Kondo A, Masuda K, Kawamoto H. Regeneration of CD8alphabeta T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity. Cancer Res. 2016;76:6839-6850
  53. Kataoka K, Ogawa S. Variegated RHOA mutations in human cancers. Exp Hematol. 2016;44:1123-1129
  54. Ando M, Kawazu M, Ueno T, Koinuma D, Ando K, Koya J, Kataoka K, Yasuda T, Yamaguchi H, Fukumura K, Yamato A, Soda M, Sai E, Yamashita Y, Asakage T, Miyazaki Y, Kurokawa M, Miyazono K, Nimer SD, Yamasoba T, Mano H. Mutational Landscape and Antiproliferative Functions of ELF Transcription Factors in Human Cancer. Cancer Res. 2016;76:1814-1824
  55. Kataoka K, Ogawa S. Genetic biomarkers for PD-1/PD-L1 blockade therapy. Oncoscience. 2016;3:311
  56. Iizuka H, Kagoya Y, Kataoka K, Yoshimi A, Miyauchi M, Taoka K, Kumano K, Yamamoto T, Hotta A, Arai S, Kurokawa M. Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis. Exp Hematol. 2015;43:849-857
  57. Morita K, Masamoto Y, Kataoka K, Koya J, Kagoya Y, Yashiroda H, Sato T, Murata S, Kurokawa M. BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4. Leukemia. 2015;29:2248-2256
  58. Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G, Ishii R, Muto S, Kotani S, Watatani Y, Takeda J, Sanada M, Tanaka H, Suzuki H, Sato Y, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Iwanaga M, Ma G, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Ogasawara H, Sato T, Sasai K, Muramoto K, Penova M, Kawaguchi T, Nakamura H, Hama N, Shide K, Kubuki Y, Hidaka T, Kameda T, Nakamaki T, Ishiyama K, Miyawaki S, Yoon SS, Tobinai K, Miyazaki Y, Takaori-Kondo A, Matsuda F, Takeuchi K, Nureki O, Aburatani H, Watanabe T, Shibata T, Matsuoka M, Miyano S, Shimoda K, Ogawa S. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet. 2015;47:1304-1315
  59. Suzuki H, Aoki K, Chiba K, Sato Y, Shiozawa Y, Shiraishi Y, Shimamura T, Niida A, Motomura K, Ohka F, Yamamoto T, Tanahashi K, Ranjit M, Wakabayashi T, Yoshizato T, Kataoka K, Yoshida K, Nagata Y, Sato-Otsubo A, Tanaka H, Sanada M, Kondo Y, Nakamura H, Mizoguchi M, Abe T, Muragaki Y, Watanabe R, Ito I, Miyano S, Natsume A, Ogawa S. Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet. 2015;47:458-468
  60. Yoshizato T, Dumitriu B, Hosokawa K, Makishima H, Yoshida K, Townsley D, Sato-Otsubo A, Sato Y, Liu D, Suzuki H, Wu CO, Shiraishi Y, Clemente MJ, Kataoka K, Shiozawa Y, Okuno Y, Chiba K, Tanaka H, Nagata Y, Katagiri T, Kon A, Sanada M, Scheinberg P, Miyano S, Maciejewski JP, Nakao S, Young NS, Ogawa S. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med. 2015;373:35-47
  61. Hosoi M, Kumano K, Taoka K, Arai S, Kataoka K, Ueda K, Kamikubo Y, Takayama N, Otsu M, Eto K, Nakauchi H, Kurokawa M. Generation of induced pluripotent stem cells derived from primary and secondary myelofibrosis patient samples. Exp Hematol. 2014;42:816-825
  62. Sato T, Goyama S, Kataoka K, Nasu R, Tsuruta-Kishino T, Kagoya Y, Nukina A, Kumagai K, Kubota N, Nakagawa M, Arai S, Yoshimi A, Honda H, Kadowaki T, Kurokawa M. Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. Oncogene. 2014;33:5028-5038
  63. Sato Y, Maekawa S, Ishii R, Sanada M, Morikawa T, Shiraishi Y, Yoshida K, Nagata Y, Sato-Otsubo A, Yoshizato T, Suzuki H, Shiozawa Y, Kataoka K, Kon A, Aoki K, Chiba K, Tanaka H, Kume H, Miyano S, Fukayama M, Nureki O, Homma Y, Ogawa S. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome. Science. 2014;344:917-920
  64. Kagoya Y, Yoshimi A, Kataoka K, Nakagawa M, Kumano K, Arai S, Kobayashi H, Saito T, Iwakura Y, Kurokawa M. Positive feedback between NF-kappaB and TNF-alpha promotes leukemia-initiating cell capacity. J Clin Invest. 2014;124:528-542
  65. Kobayashi CI, Takubo K, Kobayashi H, Nakamura-Ishizu A, Honda H, Kataoka K, Kumano K, Akiyama H, Sudo T, Kurokawa M, Suda T. The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells. Blood. 2014;123:2540-2549
  66. Kataoka K, Sato T, Kurokawa M. Identification of long-term repopulating hematopoietic stem cells by Evi1. Inflammation and Regeneration. 2013;33:175-180
  67. Kataoka K, Kurokawa M. Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis. Cancer Sci. 2012;103:1371-1377
  68. Kataoka K, Sato T, Yoshimi A, Goyama S, Tsuruta T, Kobayashi H, Shimabe M, Arai S, Nakagawa M, Imai Y, Kumano K, Kumagai K, Kubota N, Kadowaki T, Kurokawa M. Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. J Exp Med. 2011;208:2403-2416
  69. Nannya Y, Kataoka K, Hangaishi A, Imai Y, Takahashi T, Kurokawa M. The negative impact of female donor/male recipient combination in allogeneic hematopoietic stem cell transplantation depends on disease risk. Transpl Int. 2011;24:469-476
  70. Kagoya Y, Kataoka K, Nannya Y, Kurokawa M. Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:394-400
  71. Nakagawa M, Shimabe M, Watanabe-Okochi N, Arai S, Yoshimi A, Shinohara A, Nishimoto N, Kataoka K, Sato T, Kumano K, Nannya Y, Ichikawa M, Imai Y, Kurokawa M. AML1/RUNX1 functions as a cytoplasmic attenuator of NF-kappaB signaling in the repression of myeloid tumors. Blood. 2011;118:6626-6637
  72. Kataoka K, Nannya Y, Iwata H, Seo S, Kumano K, Takahashi T, Nagai R, Kurokawa M. Plasma brain natriuretic peptide is associated with hepatic veno-occlusive disease and early mortality after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45:1631-1637
  73. Kataoka K, Seo S, Ota S, Takahashi T, Kurokawa M. Positron emission tomography in the diagnosis and therapeutic monitoring of post-transplant lymphoproliferative disorder after cord blood transplantation. Bone Marrow Transplant. 2010;45:610-612
  74. Kataoka K, Nannya Y, Ueda K, Kumano K, Takahashi T, Kurokawa M. Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study. Bone Marrow Transplant. 2010;45:513-520
  75. Kataoka K, Takahashi T, Iwata H, Hangaishi A, Kumano K, Kurokawa M. Fulminant myocarditis after allogeneic bone marrow transplantation: successful cytomegalovirus therapy and mechanical circulatory support for bridge to recovery. Biol Blood Marrow Transplant. 2010;16:129-130
  76. Ueda K, Watadani T, Maeda E, Ota S, Kataoka K, Seo S, Kumano K, Hangaishi A, Takahashi T, Imai Y, Ohtomo K, Fukayama M, Nannya Y, Kurokawa M. Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT. Bone Marrow Transplant. 2010;45:1719-1727
  77. Kataoka K, Seo S, Sugawara Y, Ota S, Imai Y, Takahashi T, Fukayama M, Kokudo N, Kurokawa M. Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature. Leuk Lymphoma. 2010;51:1494-1501
  78. Kataoka K, Ichikawa M, Hangaishi A, Takahashi T, Imai Y, Kurokawa M. Interstitial pneumonia associated with progression of myelodysplastic syndrome. Int J Hematol. 2009;89:718-719
  79. Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T, Kurokawa M. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15:195-204
  80. Kataoka K, Izutsu K, Nagai S, Hangaishi A, Motokura T, Takahashi T, Kurokawa M. Elevated serum levels of soluble interleukin-2 receptor in chronic eosinophilic leukemia/hypereosinophilic syndrome with FIP1L1-PDGFR alpha fusion gene. Int J Hematol. 2008;87:440-441
  81. Kataoka K, Yamamoto G, Nannya Y, Yoshimi A, Okada S, Asai T, Kumano K, Hangaishi A, Takahashi T, Chiba S, Kurokawa M. Successful engraftment following HLA-mismatched cord blood transplantation for patients with anti-HLA Abs. Bone Marrow Transplant. 2008;42:129-130
  82. Kataoka K, Taguchi M, Takeshita A, Miyakawa M, Takeuchi Y. Recurrence of primary hyperparathyroidism following spontaneous remission with intracapsular hemorrhage of a parathyroid adenoma. J Bone Miner Metab. 2008;26:295-297